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(6,7)-Br2-PC 1-Palmitoyl-2-(6,7-dibromostearoyl)phosphatidylcholine
(9,10)-Br2-PC          1-Palmitoyl-2-(9,10-dibromostearoyl)phosphatidylcholine
(11,12)-Br2-PC       1-Palmitoyl-2-(11,12-dibromostearoyl)phosphatidylcholine
CD                          Circular dichroism
d                             Distance from the center of the bilayer
DPH                          Diphenylhexatriene
F                                Fluorescence emission intensity
HMC                          Hoffman modulation contrast
Ie                                Excimer fluorescence intensity of pyrene at 480 nm
Im                               Monomer fluorescence intensity of pyrene at 398 nm
Ksv                              Stern-Volmer quenching constant
LPS                            Lipopolysaccharide
LTA                 Lipoteichoic acid
LUVs                         Large unilamellar vesicles
PC                              Phosphatidylcholine
PG                              Phosphatidylglycerol
PLA2                          Phospholipase A2
sPLA2                         Secretory phospholipase A2
POPG                         1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol
PPDPC                       1-Palmitoyl-2-[10-(pyren-1-yl)decanoyl]-
                                    sn-glycero-3-phosphocholine
PPDPG                       1-Palmitoyl-2-[10-(pyren-1-yl)decanoyl]-
                                   sn-glycero-3-phospho-rac-glycerol
PPHPC                       1-Palmitoyl-2-[6-(pyre-1-yl)]hexanoyl-
                                   sn-glycero-3-phosphatidylcholine
PPHPM                      1-Palmitoyl-2-[6-(pyre-1-yl)]hexanoyl-
                                   sn-glycero-3-phosphatidylmonomethylester
r                                  Anisotropy of diphenylhexatriene
RFIm                           Relative fluorescence intensity of pyrene monomers
RFIe                            Relative fluorescence intensity of pyrene excimers
R(Ie/Im)                       Relative excimer to monomer ratio of pyrene fluorescence
SOPC                         1-Stearoyl-2-oleoyl-sn-glycero-3-phosphocholine
9SR-1                           (2S,3R) -2,3-dimethoxy-1,4-bis(N-hexadecyl-N,N-
                                   dimethylammonnium)butane dibromide
SUVs                          Small unilamellar vesicles
X                                 Mole fraction of the indicated lipid
π                                 Surface pressure
πc                                Critical surface pressure abolishing the intercalation of the
                                   peptides into the lipid monolayers
π0                                                Initial surface pressure
∆π                               Increment in surface pressure
∆Im/∆[M]                    Slopes for the increase in Im due to peptides before reaching
                                   saturating responses in RFIm
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ABSTRACT
The antimicrobial peptides are cytolytic peptides that serve in the vertebrates and
invertebrates for both offensive and defensive purposes. They can rapidly kill a broad
range of microbes and have additional activities that impact on the quality and
effectiveness of innate responses and inflammation. Furthermore, the challenge of
bacterial resistance to conventional antibiotics and the unique mode of action of
antimicrobial peptides have made such peptides promising candidates for the
development of a new class of antibiotics. Accordingly, the molecular basis of their
action is of considerable interest and requires to be elucidated. The present study thus
focused on the interactions of the four antimicrobial peptides, magainin 2, indolicidin,
temporin B and L with model biomembranes, as well as their potential to impact the
activity of secretory phospholipase A2. In brief, the results show that these peptides
are highly membrane active and they readily intercalate into lipid monolayers. The
penetration was significantly enhanced by the presence of acidic phospholipids.
Similarly, the effects of the antimicrobial peptides on lipid dynamics were
significantly stronger in bilayers containing acidic phospholipids and they increased
the acyl chain order and caused lipid segregation. However, the effects of magainin 2,
indolicidin, temporin B and L on lipid dynamics in bilayers were attenuated by the
presence of cholesterol. Interestingly, all the four antimicrobial peptides induced an
endocytosis-like process in the acidic phospholipid containing giant liposomes
although the formed aggregated structures were different. The phosphatidylcholine
(PC) membranes were unaffected by magainin 2, indolicidin, and temporin B.
Likewise, magainin 2 and temporin B had little impact on giant liposomes composed
of PC/cholesterol (Xchol=0.1). In contrast, temporin L induced pronounced
vesiculation of both PC and PC/cholesterol giant vesicles and indolicidin had a
significant effect on PC/cholesterol membranes. The results indicate that temporin L
and indolicidin interact also with neutral membranes, in keeping with their hemolytic
activities. Indeed, temporin L inserted into both zwitterionic and acidic membranes
with similar depth of ≈ 8.0 ± 0.5 Å from the center of the bilayer, with defined α-
helical structure. However, in the presence of cholesterol the partitioning of temporin
L into lipid bilayers was reduced and the insertion of this peptide into the membrane
was shallow, with a distance of 9.5 ± 0.5 Å from the center of the bilayer.
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Increasing evidence indicates that antimicrobial peptides act through a variety of
mechanisms other than disruption of membrane integrity, and that their role in host
defense goes well beyond direct killing of microorganisms. Indeed, the four
antimicrobial peptides, magainin 2, indolicidin, temporin B and L caused pronounced
effects on the activities of secretory phospholipase A2 (sPLA2) from bee venom and
human lacrimal fluid. The activity of sPLA2 towards anionic liposomes was
significantly enhanced by the antimicrobial peptides while their impact on the
hydrolysis of the zwitterionic membranes by sPLA2 was dependent on the
concentration of Ca2+ and the origin of sPLA2. The effects of the four antimicrobial
peptides on sPLA2 activity were suggested to depend on lipid compositions in a
manner showing a bacterial membrane to be susceptible to enhanced hydrolysis while
the host cell membrane would remain intact. Interestingly, inclusion of a cationic
gemini surfactant in the vesicles showed essentially similar pattern on sPLA2 activity,
indicating that modulation of the enzyme activity by the antimicrobial peptides may
involve charge properties of the substrate surface. The results highlight the potential
of concerted action between sPLA2 and antimicrobial peptides as part of the innate
response to infections, particularly when more antibiotic resistant bacterial strains are
emerging.
12
1 INTRODUCTION
All organisms need protection against microorganisms and their ability to prevent the
onset of infection is believed to depend on their innate immune response. The
inducible effectors of the innate immune response are rapidly induced (within minutes
or hours), relatively non-specific, and have conserved molecular patterns of
recognition of stimulatory molecules including bacterial lipopolysaccharide (LPS) and
lipoteichoic acid (LTA). In contrast, the adaptive humoral and cellular immune
responses have minimal impact on whether these pathogens will cause infections in
unimmune animals because a primary response involving clonal expansion of slow-
growing B and T cells takes up to several days (three days for secondary response)
before it is even noticeable. The effectors of the innate immune response have
traditionally been thought to include phagocytic cells, such as neutrophils and
macrophages, other leukocytic cells (e.g. mast cells), and serum proteins such as
complement. During the past two decades, living organisms of all types have been
found to produce a large repertoire of antimicrobial peptides that play an important
role in innate immunity to microbial invasion. In higher organisms they are mainly
produced on epithelial surfaces and in phagocytic cells that play a crucial role in the
innate as well as the adaptive defense systems (Ganz and Lehrer, 1995; Simmaco et
al., 1998; Hancock and Scott, 2000; Yang et al., 2001). Antimicrobial peptides exhibit
rapid killing, often within minutes in vitro, and a broad spectrum of activity against
various targets, including Gram-positive and -negative bacteria, fungi, parasites,
enveloped viruses,  and tumor cells (Baker et al., 1993; Hancock and Scott, 2000;
Chen et al., 2001; Fernandez-Lopez et al., 2001; Zasloff, 2002). In addition, their
antimicrobial activity can be enhanced by the synergy between individual cationic
peptides within a host, and between the peptides and other host factors, such as
lysozyme (Hancock and Scott, 2000). Hundreds of antimicrobial peptides have been
isolated so far and irrespective of their origin, spectrum of activity, and structure,
most of these peptides share several common properties. They are generally
composed of < 60 amino acid residues (mostly common L-amino acids), their net
charge is positive, they are amphipathic, and in most cases they are membrane active.
The interaction of antimicrobial peptides with membranes alters the organization of
the bilayer and makes it permeable, causing membrane depolarization (Matsuzaki et
al., 1997; Kourie and Shorthouse, 2000). This has led to the general conclusion that
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the interaction of most antimicrobial peptides with membranes, involving electrostatic
and hydrophobic interactions, is a necessary precursor to cell death. However, it
should be underlined that alternative and/or coexistent antimicrobial mechanisms
cannot be ruled out at this stage, and evidence is accumulating that some peptides
might actually act by binding to intracellular targets, or by stimulating host defense-
mechanisms (Li et al., 1995; Hancock and Rozek, 2002; Gennaro et al., 2002).
Indeed, certain peptides have been found to interact directly with host cells to
stimulate host gene products, including specific chemokines, chemokine receptors,
integrins, transcriptional factors etc. (Hancock and Scott, 2000). Furthermore, it has
been suggested that the cationic antimicrobial peptides have many potential roles in
inflammatory responses, which represent an orchestration of the mechanisms of
innate immunity (Hancock and Diamond, 2000).
The development of new families of antibiotics that can overcome the resistance
problem has become a very important task because of the emergence of resistant
bacterial strains worldwide (Bonomo, 2000). The killing mechanism of antimicrobial
peptide is such different from that of the conventional antibiotics that antimicrobial
peptides are considered as attractive substitute and/or additional drugs. The
elucidation of the mechanisms of the action of antimicrobial peptides and their
specific membrane damaging properties, viz. their selectivity to a specific target, is
supposed to be a key for the rationale design of novel types of peptide-antibiotics
(Lohner, 2001).
The purpose of this study was to elucidate the membrane activity and specificity of
four antimicrobial peptides, magainin 2, indolicidin, temporin B and L. The effects of
these antimicrobial peptides on the activity of secretory phospholipase A2 was also
studied. The peptides employed in our investigations were chosen as they represent
different types of antimicrobial peptide families. These peptides differ in structural
parameters such as charge, conformation, hydrophobicity, hydrophobic moment, and
size. In this study, different membrane models, viz. monolayers, large and small
unilamellar vesicles, as well as giant liposomes, respectively, were used to investigate
the penetration of these four antimicrobial peptides into films, their effects on the
dynamics of lipids in bilayers, and macroscopic, morphological changes in
membranes. In addition, the structure, orientation, and depth of penetration of
14
temporin L into lipid bilayers were studied in more detail. Characterization of
peptide-membrane interactions, membrane lysis by antimicrobial peptides, as well as
the topology of the peptides in membranes provided insight into the mode of their
action and the effect of different lipids on their function and selectivity. Furthermore,
the potential of concerted action between antimicrobial peptides and sPLA2, which
could improve the efficiency of the innate response to infections, would highlight the
application of antimicrobial peptides as therapeutic agents.
15
2 REVIEW OF THE LITERATURE
Antimicrobial peptides are widely distributed in nature and represent an ancient
mechanism of host defense (Lehrer and Ganz, 1999). They were initially found in
invertebrates (Boman, 1991), and later also in vertebrates, including humans
(Gudmundsson et a., 1996). Antimicrobial peptides are promptly synthesized at low
metabolic cost, easily stored in large amounts and readily available shortly after an
infection, to rapidly neutralize a broad range of microbes. Most antimicrobial peptides
tested so far, regardless of sequence, size, charge, diastereomerism, L- or D-amino
acid composition and structure, kill bacteria in the micromolar range supporting a
non-receptor mediated mechanism for their mode of action (McElhaney and Prenner,
1999). Numerous studies indicate that many antimicrobial peptides act directly on the
membrane of the target cell (for reviews, see McElhaney and Prenner, 1999). The net
positive charge of antimicrobial peptides causes their preferential binding to more
than one negatively charged targets on bacteria, which may account for the selectivity
of antimicrobial peptides (Hancock and Scott, 2000). It has been reported that not
only the nature of the peptide but also the characteristics of cell membrane, as well as
the metabolic state of the target cells determine the mechanisms of action of
antimicrobial peptides (Liang and Kim, 1999). The action of cationic antimicrobial
peptides is not limited to direct killing of microorganisms. Instead, they have an
impressive variety of additional activities that impact particularly on the quality and
effectiveness of innate responses and inflammation (Hancock and Diamond, 2000).
The advantage for antimicrobial peptides as defense weapons, is that, given the non-
specificity of their mechanism, it is not easy for microbial pathogens to develop
resistant mutants to overcome peptide intervention. Understanding how, when and
where they function has become of considerable interest which could lead to the
development of novel therapeutic agents, especially in the context of the growing
microbial resistance to conventional antibiotics. Some antimicrobial peptides are
being developed for use either as antibiotics for topical use in healthcare or as
preservatives in the food industry (Chen et al., 2000; Nes and Holo, 2000; Zasloff,
2000; van't Hof et al., 2001; Cleveland et al., 2001). We are encouraged to believe
that antimicrobial peptides have great potential to be the next breakthrough and first
truly novel class of antibiotics.
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The purpose of this review is to summarize the biological activity and diversity of
antimicrobial peptides, the mechanisms of their action and selectivity, and to discuss
their potential as therapeutics.
2.1 Biological Activity
The antimicrobial peptides display a broad spectrum of activity. Many antimicrobial
peptides not only kill bacteria, they are cytotoxic also to fungi (Fehlbaum et al., 1996;
Kieffer et al., 2003), protozoa (Arrighi et al., 2002), malignant cells (Cruciani et al.,
1991; Baker et al., 1993; Lindholm et al., 2002), and even enveloped viruses like
HIV, herpes simplex virus, and vesicular stomatitis virus (Tamamura et al., 1998;
Robinson et al., 1998). The defining characteristic of the above targets of
antimicrobial peptides is their possession of a distinct cell membrane. Antimicrobial
peptides exhibit selectivity against different microorganisms, of which the molecular
basis is not completely understood. On the one hand, many antimicrobial peptides
display broad-spectrum activity against Gram-negative bacteria, Gram-positive
bacteria, and fungi (Miyasaki and Lehrer, 1998). On the other hand, some peptides,
e.g. andropin (Samakovlis et al., 1991) and insect defensins (Meister et al., 1997)
preferentially kill Gram-positive bacteria, while others preferentially kill Gram-
negative bacteria, e.g. apidaecin (Casteels and Tempst, 1994), drosocin (Bulet et al.,
1996), and cecropin P1 (Boman et al., 1991). Peptides that preferentially kill fungi
have also been described, e.g. drosomycin (Meister et al., 1997) and plant
antimicrobial peptides (Tailor et al., 1997). Normal human cells are relatively
resistant, but it should be mentioned that certain cationic antimicrobial peptides, such
as melittin from bees (Perez-Paya et al., 1994), mastoparan from wasps (Delatorre et
al., 2001), charybdotoxin from scorpions (Tenenholz et al., 2000), and temporin L
from frogs (Rinalti et al., 2002) are potent toxins.
The antimicrobial peptides, magainins and their analogs have been found to be able to
lyse hematopoietic tumor and solid tumor cells with little toxic effect on normal blood
lymphocytes (Cruciani et al., 1991; Baker et al., 1993). The mechanism of antitumor
activity of magainins was suggested to target cell membrane by a non-receptor
pathway (Baker et al., 1993). Tachyplesin is an antimicrobial peptide present in
leukocytes of the horse crab (Tachypleus tridentatus, Hirakura et al., 2002). A
synthetic tachyplesin conjugated to the integrin binding sequence RGD showed that it
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inhibited the proliferation of both cultured tumor and endothelia cells by disrupting
their membranes and inducing apoptosis (Chen et al., 2001). Similarly, a designed
novel peptide DPI was found to be able to trigger rapid apoptosis in tumor cells (Mai
et al., 2001). In contrast, temporin L, a 13 amino acid long peptide isolated from the
skin of the european red frog, Rana temporaria, induced necrosis of tumor cells
(Rinaldi et al., 2001; 2002). Cyclotides, members of macrocyclic cystine-knotted
peptides exhibit antimicrobial, anticancer, and antiviral activities (Tam et al., 1999;
Lindholm et al., 2002). The activity profile of cyclotides differed significantly from
those of antitumor drugs in clinical use, which may indicate a new mode of anticancer
action (Lindholm et al., 2002). Other antimicrobial peptides, such as defensins (Kagan
et al., 1990), cecropin (Moore et al., 1994), lactoferricin (Vogel et al., 2002), and
lactoferrin (Yoo et al., 1998) also have similar antitumor activity.
Several cationic amphipathic peptides also display antiviral activity in vitro.
Defensins are able to neutralize herpes simplex virus (HSV), vesicular stomatitis
virus, and influenza virus (Daher et al., 1986; Ganz and Lehrer, 1995). Tachyplesins
and polyphemusins are active against vesicular stomatitis virus, influenza A virus, and
HIV (Tamamura et al., 1996). Melittins (Wachinger et al., 1998), cecropins
(Wachinger et al., 1998), and indolicidin (Robinson et al., 1998) also display anti-HIV
activity. The generally accepted mechanism of antiviral action is a direct interaction
of these peptides with the envelope of the virus, leading to permeation of the envelope
and, eventually, lysis of the virus particle, analogous to the pore-formation model
suggested for antibacterial activity. Robinson et al. (1998) found that the antiviral
activity of indolicidin is temperature-sensitive, which was regarded as indication of a
membrane-mediated mechanism. Other mechanisms for antiviral action have also
been proposed. Peptide T22, derived from polyphemusin II, inactivates HIV-1 in vitro
by binding to both the gp120 protein of the virus and the CD4 receptor of the T-helper
cells, which may block virus-cell fusion in an early stage of the infection (Tamamura
et al., 1996). Melittin and cecropins have been found to inhibit the replication of HIV-
1 by suppression of the long terminal repeat gene (Wachinger et al., 1998).
2.2 Diversity of Antimicrobial Peptides
More than 500 antimicrobial peptides have been discovered so far from animals as
well as plants (a good collection of sequences, besides a wealth of other useful
18
information, can be found at http://www.bbcm.univ.trieste.it/~tossi/pag1.htm). The
diversity of sequences is such that the same peptide sequence is rarely recovered from
two different species of animals, even those closely related (except for the peptides
cleaved from highly conserved proteins, such as buforin II). However, both within the
antimicrobial peptides from a single species, and even between certain classes of
different peptides from diverse species, significant conservation of amino-acid
sequences can be recognized in the preproregion of the precursor molecule. The
design suggests that constrains exist on the sequences involved in the translation,
secretion or intracellular trafficking of this class of membrane-disruptive peptides.
This feature is well illustrated by cathelicidins (Zanetti, et al., 2000). The diversity of
antimicrobial peptides probably reflects the species’ adaption to the unique microbial
environments that characterize the niche occupied, including the microbes associated
with acceptable food sources (Simmaco et al., 1998; Boman, 2000). It appears
reasonable to speculate that an individual could find itself in the midst of microbes
against which the peptides of its species were ineffective, although the individual
might suffer, the species itself could survive through emergence of individuals
expressing beneficial mutations.
The diversity of antimicrobial peptides discovered is so great that it is difficult to
categorize them except broadly on the basis of their secondary structure (Epand and
Vogel, 1999; van't Hof et al., 2001). The fundamental structural principle is the ability
of a peptide to adopt a shape in which clusters of hydrophobic and cationic amino
acids are spatially organized in discrete parts of the molecule. It is common to classify
antimicrobial peptides into four groups according to their secondary structure. Table 1
describes the main structural features of some well-studied antimicrobial peptides
originating from a wide range of sources, selected as representative examples of their
structural class. This classification follows that proposed by van't Hof et al. (2001):
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Group I: linear peptides with an α-helical structure (Fig. 1, B)
One of the larger and better studied classes of antimicrobial peptides is those forming
cationic amphipathic helices, e.g. magainin, cecropin A, temporins, as well as a
number of de novo designed antimicrobial peptides (Boman, 1995; Mangoni et al.,
2000). These peptides adopt disordered structures in aqueous solution while fold into
an α-helical conformation upon interaction with hydrophobic solvents or lipid
surfaces. α-Helical peptides are often found to be amphipathic and can either absorb
onto the membrane surface or insert into the membrane as a cluster of helical bundles.
The majority of the cytotoxic amphipathic helical peptides are cationic and they do
exhibit selective toxicity for microbes. One of the most studied of the cationic,
antimicrobial, amphipathic helical peptides is magainin. This 23 amino acid peptide is
secreted on the skin of the African clawed frog, Xenopus laevis (Zasloff et al., 1987).
The properties of this peptide have recently been reviewed (Matsuzaki, 1998, 1999).
The structural parameters of this group of peptides concerning modulation of their
biological activities will be discussed in more detail below. There are also
hydrophobic or slightly anionic α-helical peptides. Peptides that are not cationic
exhibit less selectivity towards microbes compared with mammalian cells. An
example of a well-studied hydrophobic and negatively charged cytotoxic peptide is
alamethicin (Duclohier and Wroblewski, 2001; Kikukawa and Araiso, 2002). This
helical peptide forms clusters of helices that traverse the bilayer and surround an
aqueous pore transporting ions (Sansom, 1993).
Group II: conformationally more restrained peptides, predominantly consisting of β-
strands connected by intramolecular disulfide bridges (Fig. 1, A)
In contrast to the linear α-helical peptides, β-sheet peptides are cyclic peptides
constrained either by disulfide bonds, as in the case of human β-defensin-2 (Hancock,
2001), tachyplesins (Matsuzaki, 1999), protegrins (Harwig et al., 1995), and
lactoferricin (Jones et al., 1994), or by cyclization of the peptide backbone, as in the
case of gramicidin S (Prenner et al., 1999), polymyxin B (Zaltash et al., 2000), and
tyrocidines (Bu et al., 2002). They largely exist in the β-sheet conformation in
aqueous solution that may be further stabilized upon interactions with lipid surfaces.
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Defensins are among the most characterized β-sheet-forming antimicrobial peptides.
Different mechanisms involving either the perturbation of lipid bilayers or the
formation of discrete channels have been suggested for these peptides based on high
resolution crystallography (Hill et al., 1991) and 2D-NMR studies (Zhang et al.,
1992). Studies aimed at understanding the importance of the disulfide bridges for their
activity have been carried out. Detailed studies have indicated that replacement of the
cysteine residues by certain amino acids like Ala, Asp, and Leu lead to inactivation,
whereas analogs with aromatic residues Phe, Tyr, and hydrophobic amino acid like
Leu, Met, and Val retained broad spectrum antimicrobial activity (Tamamura et al.,
1998). Studies with tachyplesin analogs, where the SH groups were chemically
protected to prevent cyclization or cysteines were replaced by Ala residues, suggested
that the cyclic structure was essential for antimicrobial activity while it might not be
crucial for membrane permeabilization  (Matsuzaki et al., 1997; Tamamura et al.,
1998; Rao, 1999).
Less is known about the mechanism by which this class of antimicrobial peptides
causes membrane damage. A study of the orientation of protegrin in membranes using
oriented circular dichroism has demonstrated two different states of the peptide to
insert into a membrane, depending on the peptide concentration, the nature of the
lipid, and the extent of hydration (Heller et al., 1998). The peptide tachyplesin, which
has a cyclic anti-parallel-β-sheet structure held together by two disulfide bonds,
permeabilizes both bacterial and artificial lipid membranes. It also translocates across
lipid bilayers coupled with transient pore formation (Matsuzaki et al., 1997),
suggesting a similar mode of action as the α-helical magainin. The critical parameter
associated with the antimicrobial action of this peptide appears to be the maintenance
of a certain hydrophilic-hydrophobic balance (Rao, 1999). The effect of substitution
of a D-amino acid residue (Lys4) in a cyclic β-structure peptide (VKLKVd-
YPLKVKLd-YP), based on the sequence of gramicidin S, was determined and
resulted in high antimicrobial activity coupled with low hemolytic activity
(Kondejewski et al., 1999). The findings show that a highly amphipathic nature is not
desirable in the design of constrained cyclic antimicrobial peptides and that an
optimum amphipathicity can be defined by systematic enantiomeric substitutions.
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Group III: linear peptides with an extended structure, characterized by
overrepresentation of one or more amino acids (Fig. 1, D)
Certain antimicrobial peptides have an unusual amino acid composition, having a
sequence that is rich in one or more specific amino acids. For example, the peptide
histatin, which is produced in saliva, is highly rich in His residues (table 1, Brewer et
al., 1998; Tsai and Bobek, 1998; Helmerhorst et al., 1999a). This peptide translocates
across the yeast membrane and targets to the mitochondria, suggesting an unusual
antifungal mechanism (Helmerhorst et al., 1999a). The peptides produced by porcine
neutrophils are very rich in proline and arginine or proline and phenylalanine. They
belong to the cathelicidin family of antimicrobial peptides and are called PR-39 and
prophenin, respectively (Zhao et al., 1995; Linde et al., 2001). Tryptophan is
generally not an abundant amino acid residue in peptides or proteins. This amino acid
is of particular interest with regard to the partitioning of peptides into membranes
because of its propensity to position itself near the membrane/water interface (Yau et
al., 1998; Persson et al., 1998). Examples of antimicrobial peptides that are rich in Trp
include tritrpticin (VRRFPWWWPFLRR) (Lawyer et al., 1996) and indolicidin
(ILPWKWPWWPWRR-amide) (Selsted et al., 1992). Indolicidin was reported to
adopt a turn conformation which greatly enhances its membrane activity (Ladokhin et
al., 1999). Indolicidin has been shown to permeabilize the outer membrane of E. coli
(Falla et al., 1996; Subbalakshmi et al., 1998) to form channels, as revealed by
conductance measurements with planar bilayers (Falla et al., 1996; Wu et al., 1999).
This peptide incorporates in a highly cooperative manner within the acyl chain region
of the membrane (Ha et al., 2000) and its hemolytic activity is associated with the
concentration required for its self-association (Ahmad et al., 1995). The unusual
amino acid composition has led to studies directed towards delineation of the role of
multiple tryptophan residues in its biological activity as well as interactions with
model membranes. Several analogs have been synthesized in order to understand the
charge requirements and also the importance of Try and Pro residues for activity
(Falla et al., 1996; Subbalakshmi et al., 1996).
Group IV: peptides containing a looped structure (Fig. 1, C)
In contrast to other antimicrobial peptides, proline-arginine-rich peptides cannot form
amphipathic structures due to the incompatibility of high concentration of proline
residues in such structures and have been proposed to adopt a polyproline helical
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type-II structure (Boman et al., 1993; Cabiaux et al., 1994). Lantibiotics contain small
ring structures enclosed by a thioether bond and their structure and properties have
recently been reviewed (Montville and Chen, 1998). One of the lantibiotics, nisin, is
currently used as an antimicrobial agent for food preservation and this peptide has
relatively high activity against Gram-positive bacteria due to its specific high affinity
with Lipid II, a precursor in the bacterial cell wall synthesis (Breukink and de Kruijff,
1999; Breukink et al., 1999). Recently synthesized six- and eight residue cyclic D, L-
α-peptides have been found to exhibit high efficacy to kill bacteria with low
hemolytic activity (Fernadez-Lopez, et al., 2001). Upon binding to lipid membranes
the cyclic peptides can stack to form hollow, β-sheet-like tubular structures increasing
membrane permeability. With short size, easy to synthesize and being proteolytically
stable, this class of peptides holds considerable potential in fighting existing and
emerging infectious diseases.
Fig. 1. Molecular models of the different structural classes of antimicrobial peptides (taken from
Hancock, 2001). These models are based on two-dimensional nuclear magnetic resonance spectroscopy
of the peptides in aqueous solution for human β-defensin-2 or a membrane mimetic condition for other
peptides. (A) human β-defensin-2, which forms a triple-stranded β-sheet structure (containing a small
α-helical segment at the N-terminus) stabilized by three cysteine disulphide bridges. (B) The
amphipathic α-helical structure of magainin 2. (C) The β-turn loop structure of bovine bactenecin. (D)
The extended boat-shaped structure of bovine indolicidin.
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2.3 Induction and Regulation of Expression
Antimicrobial peptides in multicellular organisms are found on external surfaces such
as the skin or the lungs or they are sequestered in granules of neutrophils, from where
they can be released to kill microbes. Some antimicrobial peptides are synthesized
constitutively, for instance the histatins (Tsai and Bobek, 1998) and human β-
defensin-1 (Yang et al., 2002). Others are often induced in response of an infection
(Hoffmann et al., 1999) and thus can be considered as acute-phase proteins, e.g. LL-
37 (Frohm et al., 1997) and human β-defensin-2 (Harder et al., 2000; Schutte and
McCray, 2002; Yang et al., 2002). Interestingly, it has been found that plasmatic
levels of both vasostatin-1 and secretolytin increase during surgery in patients
undergoing cardiopulmonary bypass (Tasiemski et al., 2002). Vasostatin-1 and
secretolytin, initially present in plasma at low levels, are released just after skin
incision. Consequently, they can be added to enkelytin, an antibacterial peptide
derived from proenkephalin A, for the panoply of components acting as a first
protective barrier against hypothetical invasion of pathogens, which may occur during
surgery.
The large majority of antimicrobial peptides synthesized by multicellular organisms
are encoded by the genome. Insects and mammals typically express multiple
antimicrobial peptides. For example, at least ten sheep genes encode antimicrobial
peptides, including eight cathelicidins and two β-defensins (Huttner et al., 1998). The
bovine genome contains genes for at least eleven cathelicidins (Scocchi et al., 1997)
and over twenty β-defensins (Ryan et al., 1998). The antimicrobial peptides are
produced mainly through regular processes of gene transcription and ribosomal
translation, often followed by further proteolytic processing. Non-ribosomal
biosynthetic antimicrobial peptides will be not addressed in detail and recent advances
in this field are covered by a number of good review articles (Jack and Jung, 2000;
Moffitt and Neilan, 2000; Sablon et al., 2000). Magainins are synthesized as long
preproproteins containing six copies of the peptide. Proteolytic processing leads to the
release of the individual magainin peptides (Ketchem et al., 1993). The 35¯37 residue
insect cecropins are synthesized as preproproteins of 62 amino acids and processing
involves several protease activities (Gudmundsson et al., 1991). Interestingly, in many
cationic antimicrobial peptides such as the temporins, the negative charge of the
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carboxyl terminus is removed by an amidation process (Simmaco et al., 1996).
Recently, it was found that several antimicrobial peptides are released by cleavage of
intact proteins that may have no or limited antibacterial activity themselves. This has
been demonstrated first for the milk protein lactoferrin (Bellamy et al., 1992).
Proteolytic cleavage of the intact bovine protein by pepsin under acidic conditions
releases a 25 residue peptide, lactoferrin B, which shows a significantly increased
bacteriostatic potency compared to the intact protein (Bellamy et al., 1992).
Antimicrobial peptides can neutralize host responses to conserved bacterial signaling
molecules such as endotoxic LPS from Gram-negative bacteria, or LTA from Gram-
positive bacteria (O'Leary and Wilkinson, 1988). Such molecules interact with Toll-
like receptors on the surface of host cells to trigger signaling cascades and cause
upregulation of cytokines, such as tumor necrosis factor (TNF) and interleukin 6,
chemokines, and dozens of other gene products (for a review, see Medzhitov, 2001).
Differential responses are mediated by different Toll-like receptors. Accordingly,
human Toll-like receptor-2 (TLR2) is activated by bacterial lipoprotein, Gram-
positive cell walls, peptidoglycan and mycobacterial factors, whereas TLR4 is
essential for the cellular responses to LPS from Gram-negative bacteria (Shimazu et
al., 1999, Takeuchi and Akira, 2001). Although many antimicrobial peptides are
induced by bacterial molecules or upregulated by inflammatory stimuli involving a
Toll-related IL-1 receptor (Williams et al., 1997; Tauszig et al., 2000), only a few
genes encoding such inducible peptides were found. Homologous responsive elements
(Meister et al., 1997) have been identified in Drosophila. These were associated with
the Rel proteins dorsal, Dif, and relish and the inhibitory protein cactus, similar as in
the NF-kB/I-kB signaling pathway (for a review, see Imler and Hoffmann, 2000).
Drosomycin gene expression is exclusively regulated via this pathway, diptericin and
drosocin gene expressions are regulated by the independent, not yet well defined, imd
pathway, whereas gene induction for cecropin, insect defensin and the antimicrobial
protein attacin (Khush et al., 2001) requires contributions from both signaling
pathways. These pathways explain the differential response of Drosophila to fungi,
Gram-negative, and -positive bacteria. In plants, the production of inducible
antimicrobial proteins is upregulated via similar signaling pathways. For instance,
microbial products induce an intracellular proteolytic cascade in potato cells leading
to binding of nuclear factors PBF-1 and PBR-2 to an elicitor-response element (ERE)
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on the DNA (Subramaniam et al., 1997). Again, differential responses against
different types of microbes are observed (Cardinale et al., 2000) and several fungal
(Nürnberger et al., 1994; Keller et al., 1999) and bacterial (Gomez-Gomez et al.,
1999) response elicitors have been identified. Like animal cells, plant cells are able to
communicate microbial infection to neighbor cells using plant hormones as functional
analogues of interleukins. In plants two different hormone-dependent signaling
pathways have been identified that lead to differential responses to distinct
microorganisms. The salicylic acid signaling pathway induces antibacterial responses
while the cis-jasmonic acid/ethylene signaling pathway induces antifungal responses
(Thomma et al., 1998; Pieterse and Van Loon, 1999).
2.4 Molecular Basis for Antimicrobial Peptide Cell Specificity
The most interesting property of antimicrobial peptides is their cell specificity by
which they kill microbes but are nontoxic to mammalian cells. The relative
insensitivity of eukaryotic cells to antimicrobial peptides is generally ascribed to
differences in lipid composition between eukaryotic and prokaryotic cell membranes
(Dathe and Wieprecht, 1999; Matsuzaki, 1999). It has been proposed that the net
positive charge of the antimicrobial peptides accounts for their preferential binding to
the negatively charged outer surface of bacteria, which is different from the
predominantly zwitterionic surface of normal mammalian cells (Devaux, 1991; Dolis
et al., 1997). Also a less negative membrane potential in eukaryotes than in
prokaryotes plays an important role in their selectivity (Matsuzaki, 1999). Tumor cells
have lost part of their lipid asymmetry and therefore exhibit a more anionic character
on the external leaflet of their plasma membrane, which thus preferentially binds
cationic antimicrobial peptides (Utsugi et al., 1991). Furthermore, the selectivity of
some antimicrobial peptides towards tumor cells has been suggested to be due to a
higher negative membrane potential over the cytoplasmic membranes of many types
of cancer cells (Utsugi et al., 1991).
2.4.1 The potential role of lipopolysaccharide and the bacterial outer membrane
In order to develop cytolytic activity, the peptide has to ‘survive’ exposure to serum
or other media, and pass different barriers such as the extracellular matrix, or the
bacterial lipopolysaccharides, outer membrane and/or peptidoglycan layers (Andreu
and Rivas, 1999). Once it reaches the cell membrane its structures and topologies are
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in dynamic interchange (Lambotte et al., 1998; Sansom, 1998). The outer surface of
Gram-negative bacteria contains lipopolysaccharides and that of Gram-positive
bacteria, acidic polysaccharides (teichoic acids), giving the surface of bacteria a
negative charge. Additionally, the phospholipids composing the cytoplasmic
membrane of Gram-negative bacteria, and the single membrane of Gram-positive
bacteria are negatively charged. In contrast, the outer leaflet of a normal mammalian
cell is composed predominantly of zwitterionic phosphatidylcholine and
sphingomyelin phospholipids (Devaux, 1991; Dolis et al., 1997). The role of the outer
membrane and LPS on antimicrobial activity was investigated with magainin (Rana et
al., 1991). Magainin 2 alters the thermotropic properties of the outer membrane-
peptidoglycan complexes from wild-type Salmonella typhimurium and a series of LPS
mutants, which display differential susceptibility to the bactericidal activity of
cationic antibiotics. LPS mutants show a progressive loss of resistance to killing by
magainin 2 as the length of the LPS polysaccharide moiety decreases. While
disruption of outer membrane structure is not the primary factor leading to cell death
(Hancock, 1997; Guo et al., 1998), the susceptibility of Gram-negative cells to
magainin 2 has been proposed to be associated with factors that facilitate the transport
of the peptides across the outer membrane, such as the magnitude and location of LPS
charge, the concentration of LPS in the outer membrane, the outer membrane
molecular architecture, and the presence or absence of the O-antigen side chain.
Nevertheless, there is not always a direct correlation between binding of antimicrobial
peptides to LPS and their antimicrobial activity. It has been suggested that the reduced
antimicrobial activity of gramicidin S analogs results from increased affinity to outer
membrane components of Gram-negative microorganisms, competing for binding to
the inner membrane needed to cause bacteria death (Kondejewski et al., 1999). In
addition, an antimicrobial peptide that binds as oligmers onto the surface of the
bacteria will find it difficult to diffuse through the LPS layer into the target
membrane. LPS and in particular lipid A play an important role in the
pathophysiology of Gram-negative bacterial sepsis which elicits ‘endotoxic shock’
syndrome in the circulation in humans, often culminating in the death of the patient.
In principle, agents that can bind LPS released from the bacterial cell walls in the
bloodstream can neutralize its toxic action. Indeed, vertebrate and invertebrate have
proteins in their circulatory system that can bind LPS and neutralize its endotoxic
28
activity. Since various cationic antimicrobial peptides are known to bind LPS, they
may have a role in treating sepsis.
2.4.2 Role of membrane lipids
It is commonly known that a large diversity of phospholipids exists in biological
membranes, which is related to specific membrane functions due to the different
phospholipid composition and properties (Kinnunen, 1991; De Kruijff, 1997;
Dowhan, 1997). Especially the physicochemical properties of phospholipids in
microorganism membranes are of interest since it has been suggested that the lipid
composition of bacterial membranes plays an important role in the interaction with
antimicrobial peptides (Lohner and Prenner, 1999; Lohner, 2001). Cationic
antimicrobial peptides preferentially bind to membranes containing acidic
phospholipids such as PG or PS due to strong electrostatic interactions (Matsuzaki et
al., 1991, 1995a, 1998). The enhanced binding due to the presence of negatively
charged lipids could be explained by the Gouy-Chapman theory (Wenk and Seelig,
1998). This has been demonstrated with cecropins (Gazit and Shai, 1995), magainins
(Matsuzaki et al., 1999), and others (Hetru et al., 2000; Oren et al., 1999a, 1999b). In
several cases a direct correlation was found between the order of efficacy to permeate
membranes and the order of potency to kill bacteria (Oren et al., 1997). For example,
peptides with high permeating activity on PE/PG membranes matching the
composition of the inner membrane of E. coli, were highly active on this bacterium.
Likewise, the fluidity and curvature of lipid bilayers influence peptide-lipids
interactions. Fluid bilayers are generally more susceptible to the peptides. For
example, magainins more effectively permeate lipid bilayers in the liquid-crystalline
phase than those in the gel phase (Matsuzaki et al., 1991). Cholesterol affects the
fluidity and the dipole potential of phospholipid membranes, and therefore modulates
the activity of membrane-inserted peptides (Matsuzaki et al., 1995a). In addition, the
formation of hydrogen bonds between glutamates and cholesterol has been suggested
to reduce antibiotic activity (Tytler et al., 1995). Interestingly, cholesterol delays the
cell lytic effects of cecropins without abolishing them, suggesting that the peptide
inserts more slowly into cholesterol-containing membranes (Silvestro et al., 1997). A
slowing of the insertion process or a modulated association behavior might allow
proteases to remove the toxins from the cellular surface (Resnick et al., 1991;
Silvestro et al., 1997; Andreu and Rivas, 1999).
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The importance of curvature strain in the functions of membrane associated peptides
and proteins has attracted a great deal of attention (Epand, 1998). If the head group of
a lipid possesses a size comparable to the cross-section of the acyl chains the lipid has
a cylindrical shape and the lipids form a flat monolayer with zero curvature (e.g.
phosphatidylcholine, Huttner and Schmidt, 2002). In contrast, a relatively larger polar
headgroup results in a convex monolayer with positive curvature (e.g. lyso-
phospholipids), whereas a smaller hydrophilic group causes concave bending of the
monolayer with negative curvature (e.g. phosphatidylethanolamine). Incorporation of
phosphatidylethanolamine was found to inhibit the magainin-induced pore formation
in the inhibitory order of dioleoylphosphatidylethanolamine > dielaidoylphospha-
tidylethanolamine (Matsuzaki et al., 1998). However, addition of a small amount of
palmitoyllysophosphatidylcholine enhanced the peptide-induced permeabilization of
phosphatidylglycerol bilayers. These results suggest that the peptide imposes positive
curvature strain, facilitating the formation of a torus-type pore, and that the presence
of negative curvature-inducing lipids inhibits pore formation. Similarly, the capacity
of gramicidin S to induce the formation of cubic or other three dimensionally ordered
inverted nonlamellar phases was suggested to increase with the intrinsic nonlamellar
phase-preferring tendencies of the lipids (Prenner et al., 1997).
2.5 Mechanisms of Action of Antimicrobial Peptides
Many antimicrobial peptides bind in a similar manner to negatively charged
membranes and permeate them, resulting in the formation of a pathway for ions and
solutes (McElhaney and Prenner, 1999). Before reaching the phospholipid membrane
peptides must transverse the negatively charged outer wall of Gram-negative bacteria
containing LPS or through the outer cell wall of Gram-positive bacteria containing
acidic polysaccharides. Hancock and coworkers described this process as a ‘self-
promoted uptake’ with respect to Gram-negative microorganisms (Hancock, 1997). In
this mechanism, the peptides initially interact with the surface LPS, competitively
displacing the divalent polyanionic cations and partly neutralize LPS. This causes
disruption of the outer membrane and peptides pass through the disrupted outer
membrane and reach the negatively charged phospholipid cytoplasmic membrane.
The membrane-active properties of such peptides have been extensively studied using
model membranes (McElhaney and Prenner, 1999). The amphipathic peptides can
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partition into cytoplasmic membrane through hydrophobic and electrostatic
interactions, causing stress in the lipid bilayer. When the unfavorable energy reaches a
threshold, the membrane barrier property is lost, which is the basis of the
antimicrobial action of these peptides.
2.5.1 Model membranes
A molecular understanding of the interaction of antimicrobial peptides with
membranes requires experimental knowledge of the structure of the membrane, the
transmembrane location of bound peptides, the structures the peptides adopt, and the
changes that occur in the membrane environment as a result of partitioning. The
interactions between an antimicrobial peptide and membranes, can be studied either
by an in vivo approach using intact cells or, alternatively, by extensive use of the in
vitro experiments with isolated or model membranes. Natural membranes are
composed of a great variety of lipids and proteins, thus studies carried out in cells
allow characterization only of the global membrane damage phenomena. Most of our
knowledge of the specific lipid-peptide interactions derived from studies on model
membranes. Among them liposomes with different size and lipid composition
represent the most promising tool. Hydration of most lipid films of various
compositions produces multilamellar vesicles (MLVs, ∅ ≈ 1 µm) which can be sized
by extrusion or sonication into large unilamellar vesicles (LUVs, ∅ ≈ 50-200 nm) or
small unilamellar vesicles (SUVs, ∅ < 50 nm), respectively (New, 1990). SUVs can
also be prepared by ethanol injection and has been shown to be indistinguishable from
those obtained by sonication (Batzri and Korn, 1973). MLVs are often applied for
solid-state NMR or DSC experiments. Optically clear SUVs are suitable for
spectroscopic measurements, especially for CD spectroscopy. Due to high degrees of
curvature which impose strain on lipid packing of SUVs, LUVs are commonly used
for most studies. However, these liposomes are submicroscopic and do not allow
resolution of morphological features relevant to more macroscopic changes in
biomembranes. The so-called giant vesicles (10-500 µm) which are spherical, closed
molecular bilayers and entrap an aqueous compartment are instead good models for
studies of undulation, budding, wounding, healing, and other manifestations of cell-
like behavior induced by membrane-acting reagents (Menger, 1998; Angelova and
Dimitrov, 1986; Angelova et al., 1999; Holopainen et al., 2000; Nurminen et al.,
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2002). Due to their large size, giant vesicles can be observed by light microscopy,
permitting direct visualization of processes involving supramolecular chemistry and
biophysics (Luisi and Walde, 2000).
Besides the above model bilayer systems, phospholipid monolayers (for a review, see
Brockman, 1999) is of interest due to their homogeneity, their stability and their
planar geometry, where the lipid molecules have specific orientation (at an air/water
interface, the heads of phospholipids point toward the water subphase and the acyl
chains toward the air). Also the two dimensional molecular density and the ionic
conditions of the subphase can be varied, as well as the temperature and composition.
Since the amphipathic character of antimicrobial peptides makes them surface-active
and their biological activity begins at lipid membrane interface, the monolayer
technique is particularly suitable to study their physicochemical and biological
properties. The interaction of peptides with phospholipids at the air/water interface
provides a unique model in understanding the insertion mechanisms of antimicrobial
peptide into cell membranes (for reviews, see Maget-Dana, 1999; Zhao et al., 2003).
2.5.2 Models presented for the mode of action of antimicrobial peptides
The action of antimicrobial peptides induces membrane defects such as phase
separation or membrane thinning, pore formation, promotion of nonlamellar lipid
structure or bilayer disruption, depending on the molecular properties of both peptide
and lipid (Lohner and Prenner, 1999). These pathways are variously termed
transmembrane pores, wormholes or toroidal pores, and channel aggregates
(Bechinger, 1999; Matsuzaki, 1999; Shai, 1999; Hancock and Scott, 2000). An
interesting ‘in plane diffusion’ model has also been proposed, where lipid-mediated
channel formation is based on the curvature stain imposed on lipid membranes in the
presence of intercalated amphipathic peptides. This model is independent of peptide
aggregation, which has been reported to be entropically and electrostatically
disfavored even in the presence of negatively charged phospholipids (Bechinger,
1999).
Two general mechanisms were originally proposed to describe the process of
phospholipid membrane permeation by membrane-active peptides, the ‘barrel-stave’
(Ehrenstein and Lecar, 1977) and the ‘carpet’ (Pouny et al., 1992) mechanisms. Fig.
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2, a cartoon illustrates both models suggested for membrane permeation. The third
mechanism, the aggregate channel formation, was also proposed for peptides without
causing significant membrane depolarization. The details of these models are as
follows:
Fig. 2. A cartoon illustrating the barrel-stave (to the left) and the carpet (to the right) models presented
for membrane permeation. In the barrel-stave model peptides first assemble on the surface of the
membrane (panel B), then insert into the lipid core of the membrane following recruitment of
additional monomers (panel C), forming pores (panel D, taken from Huang, 2000). In the carpet model
the peptides are bound to the surface of the membrane with their hydrophobic surfaces facing the
membrane and their hydrophilic surfaces facing the solvent (panel B'). When a threshold concentration
of peptide monomers is reached, the membrane is permeated and transient pores can be formed (panels
C' and D', panel D' was taken from Huang, 2000), a process that can lead also to membrane
disintegration (panel E'). The spheres represent the phospholipid headgroups and two legs connected
with these the two acyl chains. The molecules of antimicrobial peptides are illustrated as cylinders.
+A
E’’
B
C
Carpet
B'
C'
Barrel-Stave
D
D’
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2.5.2.1 The barrel-stave model
The ‘barrel stave’ mechanism describes the formation of transmembrane
channels/pores by bundles of peptides (Fig. 2, B-D). Progressive recruitment of
additional peptide monomers leads to a steadily increasing pore size. Leakage of
intracellular components through these pores subsequently causes cell death. To allow
pore formation the inserted molecules should have distinct structures, such as, an
amphipathic or hydrophobic α-helix, β-sheet, or both α-helix and β-sheet structures.
A crucial step in the barrel stave mechanism requires peptides to recognize one
another in the membrane bound state. Peptide assembly can occur on the surface or
within the hydrophobic core of  the membrane, since hydrophobic peptides can span
membranes as monomers (Ben Efraim and Shai, 1997). In contrast, it is energetically
unfavorable for a single amphipathic α-helix to transverse the membrane as a
monomer. The low dielectric constant and inability to establish hydrogen bonds
prohibits direct contact of the hydrophobic core of the membrane with the polar face
of a single amphipathic α-helix. Therefore such monomers must associate on the
surface of the membrane before insertion and the inserted peptides associated in
membranes such that their non-polar side chains face the hydrophobic lipid core of
the membrane and the hydrophilic surfaces of peptides point inward into the water-
filled pore. An amphipathic α-helical peptide with a highly homogeneously charged
hydrophilic face cannot form a transmembrane pore unless its charges become
neutralized. It is therefore unlikely that antimicrobial peptides with a large number of
lysines or arginines spread along the peptide chain will permeate the membrane by
barrel-stave mechanism.
Because these peptides insert into the hydrophobic core of the membrane, they should
have two important properties (Shai and Oren, 2001): (i) their interaction with the
target membrane is driven predominantly by hydrophobic interactions. (ii) if they
adopt amphipathic α-helical structure, their net charge along the peptide backbone
should be close to neutral. Alternatively they can be composed of predominantly
hydrophobic amino acids (Ben Efraim et al., 1993). As a consequence of these
properties the peptides bind to phospholipid membranes irrespective of the membrane
charge, and therefore, should be toxic to both bacteria and normal mammalian cells.
Indeed, functional studies revealed that pardaxin (Rapaport and Shai, 1991),
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alamethicin (Sansom, 1993), and the helix α5 of δ-endotoxin (Gazit et al., 1994) kill
both bacteria and erythrocytes by the barrel-stave mechanism.
2.5.2.2 The carpet model
Early studies suggested that antimicrobial peptides kill microorganisms by forming
transmembrane pores presumably via the barrel-stave mechanism (Matsuzaki et al.,
1991). However, the interaction of certain antimicrobial and lytic peptides with
membranes clearly differentiated from the barrel-stave pore formation and a new
mechanism was suggested. The carpet model was proposed for the first time to
describe the mode of action of dermaseptin S (Pouny et al., 1992), and later on was
used to describe the mode of action of other antimicrobial peptides, such as
dermaseptin natural analogues (Ghosh et al., 1997), cecropins (Gazit et al., 1995), the
human antimicrobial peptide LL-37 (Oren et al., 1999a), caerin 1.1 (Wong et al.,
1997), trichogin GA IV (Monaco et al., 1999), and diastereomers of lytic peptides
(Oren et al., 1999b; Sharon et al., 1999; Oren and Shai, 2000). According to the carpet
model, the peptides first bind onto the surface of the target microbial cell membrane
and subsequently the membrane is covered by a ‘carpet-like’ cluster of peptides (Fig.
2, B'). Initial interaction with the negatively charged target membrane is electrically
driven. In the second step, after a threshold concentration has been reached, the
peptides cause membrane permeation (Fig. 2, C' and D'). This model further suggests
that the membrane breaks into pieces and leads to lysis of the microbial cell when a
threshold concentration of peptide is reached (Oren and Shai, 1998, Fig. 2, E'). High
local concentration on the surface of the membrane depends upon the type of the
target membrane and can occur either after all the surface of the membrane is covered
with peptide monomers, or alternatively, antimicrobial peptides that associate on the
surface of the membrane can form a local carpet. At an intermediate stage wormhole
formation has been suggested to occur (Fig. 2, C' and D'). Pores like these may enable
the passage of low molecular weight molecules prior to complete membrane lysis.
The formation of so-called wormholes or toroidal pores was proposed to describe the
mode of action of dermaseptin (Mor and Nicolas, 1994), magainin (Ludtke et al.,
1996; Matsuzaki et al., 1995b, 1996; Yang et al., 2000), protegrin (Heller et al.,
1998), and melittin (Yang et al., 2001). Neutral in-plane scattering data showed that
pores of magainin molecules are almost twice as large as the alamethicin pores and
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suggested that the lipid layer bends back on itself like the inside of a torus (Ludtke et
al., 1996). This requires a lateral expansion in the polar headgroup region of the
bilayer, which is filled up by individual peptide molecule. The positively charged
amino acids are spread along the peptide chain of magainin and continuously in
contact with the phospholipid head group during the process of peptide permeation,
even when the peptide oriented perpendicular to the membrane plane. A structure of
organized holes composed of lipids and peptides were recently reported (Yang et al.,
2000). The presence of negatively charged lipids is important for a peptide carpet to
form, as they help to reduce the repulsive electrostatic forces between positively
charged peptides. In addition, high local peptide concentrations are achieved when
cationic peptides phase-separate into domains rich in acidic phospholipids (Latal et
al., 1997). The carpet model describes a situation in which these peptides are in
contact with the phospholipid head group throughout the entire process of membrane
permeation. Furthermore, a peptide that permeates the membrane via this mechanism
can adopt different secondary structures, lengths, and can be either linear or cyclic
upon its binding to the membrane. The net charge of the peptides needs to be highly
positive and spread along the peptide chain that they only bind very weakly, or not
bind zwitterionic membranes. However, highly positively charged antimicrobial
peptides can lyse erythrocytes membranes if they form oligomers in solution (Shai
and Oren, 2001).
In brief, peptides that act via the carpet mechanism and remain in contact with the
acidic phospholipid head groups, should have the following properties (Shai and
Oren, 2001): (i) their net charge needs to be highly positive and spread along the
peptide chain. (ii) they should bind very weakly, or not bind zwitterionic membranes
and as a consequence not be hemolytic. It should be noted however, that highly
positively charged antimicrobial peptides can lyse erythrocytes if they form oligomers
in solutions (iii) no preferable structure is required, as long as a certain level of
hydrophobicity and number of positive charges are preserved.
2.5.2.3 The aggregate channel model
Both the carpet and the barrel-stave models predict that killing activity of
antimicrobial peptides occurs with concomitant dissipation of the membrane potential,
due to the collapse in membrane integrity. However, although permeabilization of the
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cell membrane seems necessary, several studies indicate that permeabilization alone
may not be enough to explain antimicrobial activity (Ganz and Lehrer, 1995). Planar
lipid bilayer model studies showed that transient conductance events indicative of
pore formation were only seen at high concentrations of peptides and high
transmembrane voltages (Wu et al., 1999). The magnitude of these conductance
effects exhibited little correlation with the antimicrobial potency. Some peptides, e.g.
bactenecin, did cause membrane depolarization at their minimal inhibitory
concentrations. However, other peptides, e.g. gramicidin S, caused maximal
membrane depolarization at a concentration well below their minimal inhibitory
concentrations. This implicates that membrane depolarization by itself is not
necessarily the crucial event in the killing of microorganisms and thus the aggregate
channel model is proposed (Hancock and Chapple, 1999). After binding to the
phospholipid head groups, the peptides insert into the membrane and then cluster into
unstructured aggregates that span the membrane. These aggregates are proposed to
have water molecules associated with them providing channels for leakage of ions and
possibly larger molecules through the membrane. This model essentially differs from
the other two: only short-lived transmembrane clusters of an undefined nature are
formed, which allow the peptides to cross the membrane without causing significant
membrane depolarization. Once inside, the peptides home to their intracellular targets
to exert their killing activities. Recently, NMR study with indolicidin revealed an
interesting fold, comprised of a hydrophobic core flanked by two dispersed, positively
charged regions. Due to its central hydrophobic core, it was suggested that indolicidin
inserts into the hydrophobic core of the membrane and forms channel aggregates
(Rozek et al., 2000).
2.5.3 Alternative mechanisms of action: intracellular targets of antimicrobial
peptides
Most antimicrobial peptides act directly on lipid bilayers of the target membrane,
rather than on a receptor, as discussed in detail above. However, studies with several
antimicrobial peptides have shown that all-L and all-D enantiomers are not of equal
activity and the results appear to be strongly species dependent (Vunnam et al., 1997).
For an example, the all-D isomers of apidaecin (Casteels and Tempst, 1994) and
drosocin (Bulet et al., 1996) are no longer active, pointing to a stereo-specific
interaction. A stereospecific complementarity between the peptide and a bacterial
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receptor might exist, at least in certain bacterial species. Receptor-mediated signaling
activities of some peptides have also been reported (Hoffman et al., 1999). Likewise,
the antimicrobial peptides might target intracellular molecules, such as DNA or
enzymes, since they are capable of spontaneously traversing bacterial outer and inner
membranes. Recently, indolicidin was proposed to inhibit DNA synthesis leading to
filamentation in E. coli (Subbalakshmi and Sitaram, 1998). Accordingly, increasing
evidence indicates that antimicrobial peptides could also act through a variety of
mechanisms other than disruption of membrane integrity, and that their role in host
defense goes well beyond direct killing of microorganisms. For example, stimulation
of host defense-mechanisms by antimicrobial peptides is becoming apparent in
several cases. Among these antimicrobial peptides, dermaseptin, which was found to
stimulate the release of myeloperoxidase and the production of reactive oxygen
species by polymorphonuclear leukocytes (Ammar et al., 1998). Also defensins can
enhance the recruitment of neutrophils to the infected tissue (Welling et al., 1998),
thus increasing the ability of the host to resist local infections. Some antimicrobial
peptides were found to interfere with the metabolic processes of microbes.
Accordingly, the glycine-rich attacins block the transcription of the omp gene in E.
coli (Carlsson et al., 1991), whereas magainins and cecropins induce selective
transcription of its stress-related genes micF and osmY at sublethal concentrations (Oh
et al., 2000). Bac5 and Bac7 inhibit protein and RNA synthesis of E. coli and
Klebsiella pneumoniae by inhibition of the respiration in addition to their potential to
disturb the membranes of these bacteria (Skleravaja et al., 1990). PR-39 binds to the
cell membrane of E. coli without causing permeabilization (Cabiaux et al., 1994), but
kills bacteria solely by stopping both DNA and protein synthesis (Boman et al.,
1993). Similarly, buforin II inhibits the cellular functions of E. coli by binding to
DNA and RNA after penetrating the cell membranes (Park et al., 1998). Another
emerging view is that many peptides act synergistically with other host molecules
with antimicrobial activity to kill microbes. Positive cooperativity has been reported
between peptides and lysozyme, and between different antimicrobial peptides
(McCafferty et al., 1999; Hancock and Scott, 2000; Kobayashi et al., 2001). More in
general, it is becoming clear that there exists a certain degree of coupling between the
innate and adaptive immune systems with antimicrobial peptides having a large
impact on the quality and effectiveness of immune and inflammatory responses (Raj
and Dentino, 2002). Although the present scenario is far to be complete, excellent
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reviews are available that highlight recent examples of these intriguing themes
(Hancock and Diamond, 2000; Hancock and Scott, 2000; Hancock, 2001).
2.6 The Potential of Structural Features of α-helical Antimicrobial Peptides to
Modulate Activity on Model Membranes and Cells
Antimicrobial peptides that assume an amphipathic α-helical structure are widespread
in nature and most studied. Their activity depends on several parameters, including
the sequence, size, degree of structure formation, cationicity, hydrophobicity and
amphipathicity, which can be used as starting points in the rational design of
antimicrobial peptides with reduced hemolytic activity (Dathe and Wieprecht, 1999).
Although the individual importance of each of these features is difficult to determine,
as they all influence each other, some general trends have emerged from studies with
model peptides. Early studies directed towards enhancing membrane activity and
improving the antimicrobial effect were based on appropriate amino acid substitutions
to increase peptide helicity. Helicity is essential for the activity against neutral
(eukaryotic) membranes, but seems less important for the activity against negatively
charged (prokaryotic) ones. Breaking the helix by insertion of proline residues
resulted in slight decrease in antimicrobial activity, but a large decrease in hemolytic
activity and an enhanced synergy with conventional antibiotics (Zhang et al., 1999).
However, some peptides, such as magainins, completely lost their antimicrobial
activity after breaking the helix by substitutions with two consecutive D-amino acids,
whereas the activity of melittin and pardaxin remained unaffected (Shai and Oren,
1996). Recently, titration calorimetry studies confirmed that the α-helix formation is a
strong driving force for the binding to membranes (Wieprecht et al, 1999). The role
played by this parameter modulating the peptide-membrane interaction has been
further explored by several investigations. The study with the amphipathic model
peptide KLAL (KLALKLALKALKAAKLA-NH2) readily showed that the degree of
helicity plays a negligible role in the binding between the peptide and a very
negatively charged bilayer, whereas a strong effect is observed on membranes with
reduced negative charge (Dathe et al., 1996). All these results seem in agreement with
the effects observed on erythrocytes, because a decrease in helicity of KLAL analogs
correlates with a remarkable reduction in hemolytic activity, whereas both Gram-
negative and -positive bacteria are not much sensitive to the change of this parameter
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(Dathe et al., 1996). Nevertheless, more recent data concerning some synthetic small
peptides (10 amino acid long) asserted the necessity to widen these considerations,
since helicity seems to condition the antimicrobial activity of these peptides in a
significant way (Oh et al., 1999).
Amphipathicity: amphipathicity of a peptide is a measure for the spatial separation
between hydrophilic and hydrophobic side chains. It is generally determined by
calculating the hydrophobic moment, the vector sum of the hydrophobicities of each
amino acid residue perpendicular to the axis of the helix. To mutually compare the
amphipathicity of peptides with different lengths, in many studies the mean
hydrophobic moment per residue is used (Eisenberg et al., 1984). Although this
method is generally in use, the hydrophobic potential, which takes into account the
charge distribution along the axis of the helix including the gaps between individual
amphipathic stretches, would be a more accurate measure. The concept that
amphipathicity is a key feature of antimicrobial peptides has initiated the de novo
design of a number of simple antimicrobial peptides that consist of repeating
sequences of alternating hydrophobic and positively charged stretches (Cornut et al.,
1994; Javadpour et al., 1996). Some investigations reported by Wieprecht and
colleagues suggest that the hydrophobic moment influences much more the activity
on neutral model membranes than on negatively charged bilayers (Wieprecht et al.,
1997a; Dathe et al., 1997). An increase of this parameter in magainin 2 analogs
causes an enhanced permeabilizing efficiency on phosphatidylcholine-rich bilayers,
whereas the negatively charged model membranes are less affected. It suggests that
hydrophobic interactions with acyl chains of lipids dominate the activity on neutral
membranes and this parameter influences the antimicrobial specificity in a negative
manner. Nevertheless, this last point of view is not in agreement with more recent
data obtained by a C-terminal fragment of melittin (Subbalakshmi et al., 1999). The
extent of its hydrophobic face causes a more remarkable increase in antibacterial
activity compared to hemolytic activity, thus providing important directions to the
design of small peptides with selective antimicrobial activity.
Hydrophobicity: hydrophobicity of the peptide is usually defined as the average of the
numeric hydrophobicity values of all residues (Eisenberg et al., 1984) and is a
measure of the ability of a peptide to move from an aqueous to a hydrophobic phase.
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This parameter measures the degree of peptide affinity for the lipid acyl chains at the
core of model and biological membranes. Most data are in agreement to associate an
increase in hydrophobicity with an enhanced permeabilizing activity on zwitterionic
bilayers. High mean hydrophobicities thus have been correlated with high cytotoxic
activities against the neutral membranes of mammalian cells (Javadpour et al., 1996;
Skerlavaj et al., 1996). Studies on histatin- and magainin-derivatives confirmed that
hemolytic activity was strongly correlated with mean hydrophobicity, but independent
of amphipathicity or net peptide charge (Helmerhorst et al., 1999b). Moreover, these
investigations also suggest that hydrophobicity plays a secondary role in the
interaction between peptides and negatively charged bilayers. The antimicrobial
activity is thus not much influenced by this parameter, and besides it seems to present
a negative correlation with the antibacterial specificity. All these observations have
been confirmed by studies on brevinin 1E amide (Kwon et al., 1998) and some
synthetic amphiphilic α-helical peptides (Kiyota et al., 1996).
Hydrophobic and hydrophilic angles: the angles subtended by the hydrophilic and
hydrophobic faces of the peptide modulate the manner in which amphipathic peptides
bind to membranes (Dathe and Wieprecht, 1999). Peptides with small hydrophilic
angles and high mean hydrophobicities tend to form transmembrane pores, whereas
peptides with equivalent hydrophobic and hydrophilic faces rather adopt a parallel
orientation upon binding to membranes. Changes in the hydrophilic angle had little
effect on the neutral lipid membranes of erythrocytes, whereas the permeabilization of
highly charged model membranes was decreased upon increase of the polar angle.
This has been found to be a very important factor in the overall peptide-bilayer
interaction because it emphasizes the differences between binding and
permeabilization. In the last years this aspect was elucidated by several investigations
on model peptides designed from magainin 2 amide which underlined that the value
of the hydrophilic angle (subtended by the positively charged helix face) correlates in
an opposite manner with the peptide-membrane affinity and the membrane
permeabilization (Wieprecht et al., 1997b). These synthetic peptides, having a
different polar angle but no other structural modification, show that the binding is
favoured by a large angle and by a negatively charged bilayer, whereas the
permeabilization is enhanced by a small angle and by a low negative membrane
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charge. Moreover both antimicrobial and hemolytic activity present a positive
correlation with an increase of the angle. Nevertheless, these and other data show that
the same increase causes a decrease in specificity against bacteria compared to
erythrocytes (Wieprecht et al., 1997b; Dathe et al., 1997). These observations are
partly confirmed by more recent investigations on two model peptides, θp100 and
θp180, which differ only in their polar angles (Uematsu and Matsuzaki, 2000).
Indeed, the binding affinity of θp180 (with a larger positive angle) for a negatively
charged bilayer, is only slightly larger than that of θp100, whereas the latter is more
effective in permeabilizing the same bilayer, thus confirming the positive correlation
between a small polar angle and the ability of a given peptide to penetrate in a lipid
bilayer to form a pore. Instead, the data on hemolytic and antimicrobial activity in this
case do not seem completely in agreement with the previous observations (Uematsu
and Matsuzaki, 2000), and that emphasizes the complexity of peptide interaction with
a biological membrane.
Charge: most cytotoxic peptides are positively charged due to the presence of lysine
and arginine residues (and, to a lesser extent, histidine) in their sequences. The net
charge of these molecules usually ranges from +2 to +9 and can vary with pH as a
result of the ionization state of various residues. Obviously, a positive charge
facilitates the binding of antimcirobial peptides to negatively charged membranes.
However, when the positive charge becomes too high, the membrane activity of the
peptides may decrease because the strong electrostatic interactions anchor the peptide
to the lipid head group region (Dathe and Wieprecht, 1999) or because the repulsion
between the positively charged side chains, intra- or intermolecular, obstructs the
formation of pores (Matsuzaki, 1999). Accordingly, there is no simple correlation
between peptide charge and membrane activity. It has been shown that the presence of
negatively charged lipids increases the local concentration of cationic peptides close
to the membrane surface and thus also their apparent association constants (Matsuzaki
et al., 1991; Silvestro et al., 1997). The charges of the peptide screen the negative
surface charge density of the lipid, therefore, the electrostatic contribution to the
binding isotherm is strongly dependent on the amount of bound peptide and saturates
at apparent charge equality (Kuchinka and Seelig, 1989). The ability of amphipathic
peptides to penetrate or to disrupt the membrane are dependent on the charge and the
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size of the lipid head group (Wieprecht et al., 1997b; Vogt and Bechinger, 1999).
Furthermore, the electrostatic interactions could arise from the presence of large
inside-negative transmembrane potentials present in respiring prokaryotic cells but
not in erythrocytes (Matsuzaki et al., 1995a). It has been suggested that
transmembrane electric potentials affect the partitioning of polypeptides between the
aqueous and the lipid phase (Stankowski et al., 1989), the orientations of peptides
within membranes (Sansom, 1993), the peptide bilayer penetration depth, and peptide
conformation (Mattila et al., 1999).
In summary, peptides with a moderately high positive charge, a large hydrophobic
moment and a small hydrophilic angle tend to have high activity against microbial
membranes, low hemolytic activity, and a preference for a carpet-like mechanism of
action. In contrast, peptides with a low positive charge, a small amphipathic moment,
and high intrinsic hydrophobicity show high activity to microbial as well as host
membranes and a preference to form barrel-stave-like pores (Shai, 1999). However,
because all the structural features discussed are strongly interrelated, it is difficult to
predict the antimicrobial activity, selectivity, and mode of action of a given peptide. A
striking example is presented by melittin, which consists of a hydrophobic N-terminal
domain, responsible for its hemolytic activity, joined by a proline hinge to a highly
selective positively charged amphipathic C-terminal domain. In this peptide, both
extremes of the spectrum discussed above are combined in one molecule.
2.7 Potential as Therapeutics
2.7.1 Introduction of peptide antibiotics on the market
The widespread increase of bacterial resistance towards many conventional antibiotics
has resulted in an intensive search for alternative antimicrobial agents (Bonomo,
2000). In this respect, antimicrobial peptides are on the brink of a breakthrough. Due
to the increasing interests of antimicrobial peptides, many companies are making
efforts to introduce the antimicrobial peptide products on the market.
Natural antimicrobial peptides have potential application in food preservation as they
specifically kill microbial cells by destroying their unique membranes. Interest in
LAB bacteriocins has been sparked by growing consumer demands for natural and
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minimally-processed foods. LAB bacteriocins have well-documented lethal activity
against foodborne pathogens and spoilage microorganisms (Cleveland et al., 2001),
and can play a vital role in the design and application of food preservation technology
(Leistner and Gorris 1995; Montville and Winkowski 1997). Currently, nisin is
approved as a food preservative in more than 40 countries worldwide (Delves-
Broughton 1990) and the use of pediocin PA-1 is covered by several European and
US patents (Vandenbergh et al. 1989; Boudreaux and Matrozza 1992). Both nisin and
pediocin PA-1 have applications in dairy and canned products. Studies of model food
systems demonstrate that pediocin-like bacteriocins are better at killing pathogens in
meat products, where nisin is ineffective (Leisner et al. 1996; Montville and
Winkowski 1997).
Antimicrobial peptides tend to be involved in a local response to infections and the
first clinical trials thus have been directed towards topical infections. Magainin
Pharmaceuticals have taken the α-helical magainin variant peptide MSI-78 into
phase-III clinical trials in studies of efficacy against polymicrobic foot-ulcer
infections in diabetes. It was announced (http://www.pslgroup.com/dg/2168e.htm)
that these trails demonstrated equivalency to orally administered ofloxacin, but with
less side effect. Applied Microbiology has initiated a trial testing the efficacy of the
bacterial lantibiotic peptide nisin against Helicobacter pylori stomach ulcers. The
antibacterial activity of nisin may not be impressive, but its endotoxin neutralizing
activity upon intravenous administration has led to a dramatically increased survival
rate. Iseganan (IB-367, Intrabiotics, Mountain View, CA, USA), a protegrin-
derivative (Mosca et al., 2000), has passed phase II clinical trials for application
against oral mucositis successfully and the company has announced plans to launch
Phase II/III clinical study to investigate iseganan HCl (Giles et al., 2002) in the
prevention of ventilator-associated pneumonia (VAP). Another formulation of this
company, iseganan HCl solution for inhalation, has completed phase I clinical trials in
cystic fibrosis patients. Other companies, for examples,  Periodontix Inc. (Watertown,
MA, USA) has entered phase I clinical trials for the application of a histatin-derived
peptide against oral candidiasis and Trimeris (Durham, NC, USA) has successfully
completed a phase II clinical trial, in which peptide T-20 (Su et al., 1999; Cohen et
al., 2002; Wei et al., 2002) reduced the viral load of HIV-infected patients with up to
44
97%. Also Demegen (Pittsburgh, PA, USA) has successfully completed animal
studies with peptide D2A21 (Robertson et al., 1998) as therapeutic for several types
of cancer and has been developing this peptide gel formulation as a wound healing
product to treat infected burns and wounds. Demegen’s P113L (histatin 5 fragment)
Oral Rinse exhibits significant binding to oral mucosal membranes and has an
excellent human safety profile in over 400 treated patients. Another product of
Demegen, P113D derived from histatins (Sajjan et al., 2001), had been granted orphan
drug status for the treatment of cystic fibrosis infections.
Interestingly, a number of evidence has shown efficacy of some antimicrobial
peptides against systemic infections, including α-helical-peptide (SMAP29, table 1)
efficacy against P. aeruginosa peritoneal infections, β-sheet-protegrin (table 1)
efficacy against methicillin-resistant S. aureus (MASA), vancomycin-resistant
Enterococcus faecalis (VRE) and P. aeruginosa infections, and indolicidin (table 1)
in liposomal formulation against Aspergillus fungal infections (Ahmad et al., 1995;
Steinberg et al., 1997; Saiman et al., 2001). Entomed (Illkirch, France) ’s product,
heliomicin (Lamberty et al., 2001) for systemic antifungal treatment is under
preclinical stage. Human lactoferricin (table 1, AM Pharma, Bunnik, Netherland) and
bactericidal/permeability-increasing protein (Xoma, Berkeley, CA, USA, Gray et al.,
1989) have also been proved to have potential for systemic applications. This has
indicated that antimicrobial peptides could be used as injectable antibiotics against
serious bacterial and fungal infections that are resistant to conventional antibiotics.
Indeed, Neuprex™, a systemic formulation of  the recombinant BPI-derived peptide
rBPI 21 (Xoma Corp., Berkeley, CA, USA, Horwitz et al., 1996), has proven to be
very effective in treatment of meningococcal sepsis in phase II/III clinical trials and
more than 1000 patients have received NEUPREX in clinical studies without any
safety concerns.
2.7.2 Novel methods for production and application of antimicrobial peptides
For peptide therapeutics, in order to become real alternatives for conventional
antibiotics and achieve similar broad applications, it is essential that their prices will
be reduced significantly as long as cheap conventional antibiotics are on the market.
Because most antimicrobial peptides are simple gene translation products, it is
45
relatively simple to produce them by recombinant expression methods at the place of
action, thus avoiding problems associated with proteolysis and rapid clearing. At first,
it may seem contradictory to express antimicrobial peptides in bacteria or yeast cells.
However, this can be achieved if the producing microorganisms are resistant to the
produced peptide antibiotic. A number of such applications are already known. In
dairy products, the addition of bacteria producing lantibiotics as natural conserving
agents has been common since the early fifties. A promising new alternative with a
lower cost is large-scale production of biologically active proteins in transgenic plants
or animals. In recent years, remarkable results have been obtained by producing
transgenic plants that express elevated levels of antimicrobial peptides in leaves and
seeds, thus potentially reducing the need for using environmentally hazardous
antibacterial or antifungal crop protecting agents (Jach et al., 1995, De Bolle et al.,
1996). This expression may also provide these plants with built-in preservation agents
that prolong their storage lives after harvesting. Recently, a modified intein
expression system was used to produce pharmaceutical peptides in transgenic plants
(Morassutti et al., 2002). Another approach to reduce the need of conventional crop
protecting agents is to use plant hormones to induce the production of innate
antimicrobial factors. Spraying of plants with cis-jasmonate-derivatives was
successful in wind-tunnel experiments (Immanishi et al., 1997) and field experiments
are currently taking place. An alternative for transgenic techniques that may be
applicable in animals or humans is gene therapy. In animal models, incorporation of
LL-37 (Bals et al., 1999) or histatin (O’Connell et al., 1996) genes in mucosa or
salivary glands, respectively, has been demonstrated to lead to an increased
antimicrobial defense. Again, the latter applications are limited to external use,
including the gastrointestinal tract. As most peptides will not survive passage through
the gastrointestinal tract, treatment protocols for systemic infections with peptide
therapeutics will be limited to injections for the time being. In specific applications,
the rapid clearing of peptides can be reduced by mixing them with a muco-adhesive
polymer (Ruissen et al., 1999) or with acrylic bone cement (Yaniv et al., 1999).
Novel formulations may also be necessary to modulate the action of antimicrobial
peptides with little intrinsic selectivity. In an animal model for fungal infection, the
high cytotoxicity of indolicidin for host cells was overcome by administration of
liposomally encapsulated material (Ahmad et al., 1995). In this respect, the
development of vehicles delivering an efficiently high concentration of peptide
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therapeutics at the right place, right time, and reasonable costs, has been becoming a
challenge for pharmacologists.
2.7.3 Limitations as therapeutics
The future of antimicrobial peptides as antibiotics appears to be great and as
mentioned above, a number of antimicrobial peptides with therapeutic potential have
been developed in the past two decades. Antimicrobial peptides are generally
considered to be highly selective antimicrobial agents. However, peptides do not
discriminate absolutely between eukaryotes and prokaryotes, although the former are
less sensitive. Several studies show that simple eukaryotes, such as yeasts, fungi,
parasites (Jaynes et al., 1988; Ahmad et al., 1995), even as large ones as planaria
(Zasloff, 2002), are effectively killed by cationic peptides. In addition, their unique
pharmacological properties have limited their application to topical use. Recent
publications describe also changes in bacterial cell wall components induced by
environmental conditions, which may be involved in bacterial resistance towards
antimicrobial peptides (Groisman et al., 1997; Wösten and Groisman, 1999).
Technical difficulties and high production costs have made the pharmaceutical
industry reluctant to invest much effort in the development of antibiotic peptide
therapeutics so far. The antimicrobial peptides are too expensive or with a too limited
spectrum to be used on a large, commercially interesting scale. The biggest challenge
of the near future will be to overcome the pharmacological limitations of these
interesting molecules and to develop them into therapeutics.
2.7.3.1 Antimicrobial peptide resistance
As a major component of host innate immunity, antimicrobial peptides can directly
contact and disrupt the bacterial membrane by permeating lipid bilayers, and
ultimately lead to cell death (Tossi et al., 2000). However, it is virtually impossible to
elicit resistance against some antimicrobial peptides (Hancock, 1997; Hancock and
Lehrer, 1998). Bacterial pathogens have developed the means to curtail the effect of
antimicrobial peptides. Direct degradation of antimicrobial peptides and modification
of cell surface properties are two major strategies used by Gram-negative bacteria to
resist the bactericidal activity of antimicrobial peptides. The former strategy is
dependent on the production of outer membrane-associated proteases, which cleave
antimicrobial peptides outside the cells and enable bacteria to evade killing. For
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example, it has been found that E. coli outer membrane protease OmpT hydrolyzes
the antimicrobial peptide protamine before it enters this bacterium (Stumpe et al.,
1998). A PhoP-regulated outer membrane protease PgtE of Salmonella typhimurium
also contributes to resistance to antimicrobial peptides (Guina et al., 2000). Because
antimicrobial peptides act on bacterial membranes, Gram-negative bacteria can also
protect themselves from attack by antimicrobial peptides via modification of their cell
surface properties to prevent the binding of antimicrobial peptides to the outer
membrane or decrease the permeability of the outer membrane (Ernst et al., 1999;
Guo et al., 1997; Guo et al., 1998). For example, two-component regulatory systems
in S. typhimurium including PhoP/PhoQ and PmrA/PmrB, promote antimicrobial
peptide resistance by activating transcription of genes that are involved in the
modification of lipid A, the bioactive component of LPS (Ernst et al., 1999; Guo et
al., 1997). The S. typhimurium PhoP/PhoQ-activated gene pagP, which is essential for
addition of palmitate to Salmonella lipid A, encodes an OMP with enzymatic activity
involved in lipid A biosynthesis (Guo et al., 1998; Bishop et al., 2000). Such lipid A
modification changes the fluidity of the outer membrane and decreases the
permeability of the outer membrane enhancing the resistance of S. typhimurium to α-
helical cationic antimicrobial peptides (Peschel, 2000). Whether other Gram-negative
bacteria use PagP-like enzymes to mediate antimicrobial peptide resistance is largely
unknown. However, PagP-mediated lipid A palmitoylation is likely a general
mechanism for Gram-negative bacterial resistance to α-helical cationic antimicrobial
peptides (Guo et al., 1998; Bishop et al., 2000). Furthermore, synergistic action of
multiple resistance strategies can greatly decrease the bactericidal activity of
antimicrobial peptides. One such example is that inactivation of both the protease
gene (pgtE) and the lipid A modification gene (pagP) in S. typhimurium resulted in
greater antimicrobial peptide sensitivity than that in mutants containing a single
mutation in either gene (Guina et al., 2000).
2.7.3.2 Immunogenicity
Another feature of peptides that may interfere with their use as therapeutics is
immunogenicity. Apparently, the mucosal antibody response to short peptides is not
very strong. However, for systemic use immunogenic safety is not that obvious. In
blood no high levels of antimicrobial peptides have been reported, and the release of
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systemically working antimicrobial peptides generally is strictly controlled.
Preliminary results in vivo suggest that antimicrobial peptides may work as single-
shot therapeutics, so that the risk of prolonged systemic concentrations high enough to
induce an IgG antibody response may be insignificant. However, certain cationic
peptides are known to have a direct effect on mast cells, leading to histamine release
without an allergenic response. Guinea pig antibacterial polypeptide CAP11,
neutrophil defensins, and histatin 5 induce a strong histamine release (Yomogida et
al., 1997; Yoshida et al., 2001). Furthermore, antimicrobial peptides may cross-react
with other receptors. A number of neuropeptides and peptide hormones with their
specific receptors are known. As they are small, often amphipathic, molecules, their
receptor-binding sites are presumed to contain only a limited number of essential
amino acids. The chance that a similar motif will be found in a peptide antibiotic may
become significant upon use of large numbers of different antimicrobial peptides in
considerably higher concentrations than endogenous peptide hormone levels. To this
end, as these paragraphs illustrate, the pharmacology and pharmacokinetics of
antimicrobial peptides are still unknown and many studies on these topics are required
before the feasibility of peptide therapeutics will be generally accepted by the
pharmaceutical industry.
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3 AIMS OF THE STUDY
The purpose of the present work was to study the molecular mechanism of membrane
activity of antimicrobial peptides and their target membrane specificity, as well as
their alternative role in innate immunity. The long-term aim of the effort is to find a
key for the rationale design of novel antimicrobial peptidomimetics.
The major aims are:
I. To assess the relative energies of peptide-lipid interactions and characterize
lipid specificity of the antimicrobial peptides, magainin 2, indolicidin,
temporin B and L.
II. To investigate the effects of the antimicrobial peptides on lipid dynamics, as
well as the structure, orientation, and depth of penetration of temporin L in
phospholipid bilayers.
III. To visualize and characterize the impact of the antimicrobial peptides on the
3-D topology of a novel biomimetic membrane model for cells.
IV. To elucidate the alternative mechanism of the antimicrobial peptides in host
defense, viz. their potential to regulate the activity of secretory phospholipase
A2.
50
4 MATERIALS AND METHODS
4.1 Materials
Hepes, EDTA, magainin 2, and bee venom phospholipase A2 were from Sigma and
indolicidin from Bachem (Bubendorf, Switzerland). Synthetic temporin B were
purchased from Tana Laboratories (Houston, TX) and temporin L was purchased
from Synpep (Dublin, CA). The purities of the peptides (> 99%, > 95%, > 90%, and >
94% for magainin 2, indolicidin, temporin B and L, respectively) were analyzed by
HPLC and their sequences were verified by both automated Edman degradation and
mass spectrometry. Peptide concentrations were determined gravimetrically and by
quantitative ion-exchange column chromatography and ninhydrin derivatization.
Human lacrimal fluid was collected from healthy donors briefly exposed to the vapors
of freshly minced onions. The collected fluid was stored at −20°C until used. 1-
Stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoglycerol (POPG), 1-palmitoyl-2-(6,7-dibromostearoyl) phosphati-
dylcholine (6,7-Br2-PC), 1-palmitoyl-2-(9,10-dibromostearoyl) phosphatidylcholine
(9,10-Br2-PC), 1-palmitoyl-2-(11,12-dibromostearoyl) phosphatidylcholine (11,12-
Br2-PC), and β-cholesterol were from Avanti Polar Lipids (Alabaster, AL). The
fluorescent phospholipid analogs 1-palmitoyl-2-[10-(pyren-1-yl)decanoyl]-sn-
glycero-3-phospho-rac-glycerol (PPDPG), 1-palmitoyl-2-[10-(pyren-1-yl)decanoyl]-
sn-glycero-3-phosphocholine (PPDPC), 1-palmitoyl-2-[6-(pyre-1-yl)]hexanoyl-sn-
glycero-3-phosphatidylcholine (PPHPC) and 1-palmitoyl-2-[6-(pyre-1-yl)]hexanoyl-
sn-glycero-3-phosphatidylmonomethylester (PPHPM) were from K&V Bioware
(Espoo, Finland). Diphenylhexatriene (DPH) was from EGA Chemie (Steinheim,
Germany). The gemini surfactant (2S,3R)-2,3-dimethoxy-1,4-bis(N-hexadecyl-N,N-
dimethylammonnium)butanedibromide (SR-1) was synthesized as described
previously (Cerichelli et al., 1996) and its purity was verified by NMR. This
compound was kindly provided by Drs. S. Borocci and G. Mancini (University of
Rome, Rome, Italy). The concentrations of the non-labeled lipids were determined
gravimetrically with a high-precision electrobalance (Cahn, Cerritos, CA) and those
of the pyrene containing phospholipids and DPH spectrophotometrically, by
absorbance at 341 nm, using molar extinction coefficients of 38000 cm-1 for PPDPC
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and PPDPG, 42000 cm-1 for PPHPC and PPHPM, and 88000cm-1 for DPH. The purity
of the lipids was checked by thin layer chromatography on silicic acid coated plates
(Merck, Darmstadt, Germany) developed with chloroform/methanol/water (65:25:4,
v/v/v). Examination of the plates after iodine staining and, when appropriate, upon
UV-illumination revealed no impurities.
4.2 Methods
4.2.1 Liposome preparation
4.2.1.1  Large unilamellar vesicles (LUVs)
The indicated lipids were mixed in chloroform after which the solvents were removed
under a stream of nitrogen and the lipid residue subsequently maintained under
reduced pressure for at least 2 h. The dry lipids were then hydrated at 50 °C and the
resulting dispersions were extruded through a stack of two polycarbonate filters (100
nm pore-size, Millipore, Bedford, MA) using a Liposofast-low pressure homogenizer
(Avestin, Ottawa, Canada) to obtain large unilamellar vesicles. The average diameters
of these LUVs are between 111 to 117 nm (Wiedmer et al., 2001).
4.2.1.2 Small unilamellar vesicles (SUVs)
Appropriate amounts of the lipid stock solutions were mixed in chloroform to obtain
the desired compositions and then dried under a stream of nitrogen followed by high
vacuum for a minimum of 2h. The lipid residues were subsequently hydrated at 50 0C
and the suspension was sonicated in a bath sonicator (Bedford, MA) until achieving
clear solutions. The vesicles were used within the same day. For the purpose of
measuring phospholipase A2 activity SUVs were formed by rapidly injecting the
indicated lipid ethanolic solution into the buffer (Batzri and Korn, 1973).
4.2.1.3 Giant vesicles
Giant liposomes were prepared as described elsewhere (Angelova and Dimitrov,
1986; Holopainen et al., 2000). Briefly, approx. 1-3 µl of the desired lipids dissolved
in diethylether:methanol (9:1, v/v, final total lipid concentration 1 mM) were spread
on the surface of two Pt electrodes and subsequently dried under a stream of nitrogen.
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Possible residues of organic solvent were removed by evacuation in vacuum for one
hour. A glass chamber with the attached electrodes and a quartz window bottom was
placed on the stage of a Zeiss IM-35 inverted fluorescence microscope. An AC field
(sinusoidal wave function with a frequency of 4 Hz and an amplitude of 0.2 V) was
applied before adding 1.3 ml of 0.5 mM Hepes buffer, pH 7.4. During the first minute
of hydration the voltage was increased to 1.0-1.2 V. The AC field was turned off after
2-4 hours and giant liposomes were observed with Hoffman modulation contrast
(HMC) optics with a 10×/0.25 objective (Modulation Optics Inc., New York, USA).
The size of giant liposomes was measured using calibration of the images by motions
of the micropipette as proper multiples of the step length (50 nm) of the
micromanipulator (MX831 with MC2000 controller, SD Instruments, Oregon, USA).
Images were recorded with a Peltier-cooled 12-bit digital CCD camera (C4742-95,
Hamamatsu, Japan) interfaced to a computer, and operated by the software (HiPic
5.0.1) provided by the manufacturer.
4.2.2 Microinjection techniques
Micropipettes with inner tip diameters of >0.5 µm were made from borosilicate
capillaries (1.2 mm outer diameter) by a microprocessor-controlled horizontal puller
(P-87, Sutter Instrument Co., Novato, CA, USA). Indicated amounts of the peptide
solutions (0.5 mM in 10 mM Hepes, 0.1 mM EDTA, pH 7.0) were applied onto the
outer surface of individual giant vesicles as series of single injection of approx. 20 fl
each and delivered with a pneumatic microinjector (PLI-100, Medical Systems Corp.,
Greenvale, NY, USA). For easier handling only vesicles attached to the electrode
surface were used. All experiments were performed at ambient temperature (approx.
+24oC) and were repeated at least 10 times.
4.2.3 Penetration of antimicrobial peptides into lipid monolayers
Penetration of peptides into monomolecular lipid films was measured using
magnetically stirred circular Teflon wells (Multiwell plate, subphase volume 1.2 ml,
Kibron Inc., Helsinki, Finland). Surface pressure (π) was monitored with a Wilhelmy
wire attached to a microbalance (Delta Pi, Kibron Inc., Helsinki, Finland) connected
to a Pentium PC. Lipids were mixed in the indicated molar ratios in chloroform and
then spread onto the air-buffer (5 mM Hepes, 0.1 mM EDTA, pH 7.0) interface.
53
Subsequently, the lipid monolayers were allowed to equilibrate for approx. 15 min at
different initial surface pressures (π0) before the injection of the peptides into the
subphase. The increments in π after the injection of peptides were complete in approx.
30 min and the difference between the initial surface pressure (π0) and the value
observed after the penetration of peptides into the films was taken as ∆π. All
measurements were performed at ambient temperature (approx. +24oC).
4.2.4 Steady state fluorescence spectroscopy
4.2.4.1 Measurement of Ie/Im
All fluorescence measurements were performed in quartz cuvettes with one cm path
length. Fluorescence emission spectra for LUVs labeled with PPDPG or PPDPC
(X=0.01) were measured with a Perkin-Elmer LS50B spectrofluorometer at 25 °C
with a magnetically stirred, thermostated cuvette compartment using excitation
wavelength of 344 nm. Band widths of 5 nm were used for both excitation and
emission. The lipid concentration used was 25 µM. After addition of appropriate
amounts of peptides, samples were equilibrated for 5 min before recording the
spectra. Three scans were averaged and the emission intensities at ≈ 398 and 480 nm
were taken for Im and Ie, respectively. All measurements were repeated three times.
4.2.4.2. Fluorescence anisotropy of DPH
DPH were included into liposomes at X=0.002. The lipid concentration used was 25
µM with temperature maintained at 25 °C. Polarized emission was measured in L-
format using Polaroid-type filters with Perkin-Elmer LS50B. Fluorescence anisotropy
r for DPH was measured with excitation at 360 nm and emission at 450 nm, using 5
nm band widths and its values were calculated using routines of the software provided
by Perkin-Elmer. All measurements were repeated three times.
4.2.4.3  Trp  fluorescent emission spectra
LUVs were added to a solution of temporin L (5 µM, final concentration) in 5 mM
Hepes, 0.1 mM EDTA, pH 7.0, with temperature maintained at 25 0C. After 3 h of
equilibration fluorescence spectra was measured with a Perkin-Elmer LS 50B
spectrometer with both emission and excitation bandpasses set at 5 nm. The
54
tryptophan residue of temporin L was excited at 280 nm and emission spectra were
recorded from 290 to 450 nm, averaging five scans. Spectra were recorded as a
function of the lipid/peptide molar ratio and corrected for the contribution of light
scattering in the presence of vesicles. Blue shifts were calculated as the differences in
wavelength of the maxima in emission spectra of lipid-peptide and peptide samples.
4.2.4.4 Quenching of Trp emission by acrylamide
To reduce absorbance by acrylamide excitation of Trp at 295 nm instead of 280 nm
was used (De Kroon et al., 1990). Aliquots of the 3.0 M solution of this water soluble
quencher were added to the peptide in the absence or presence of liposomes at
peptide/lipid molar ratio of 1:100. The values obtained were corrected for dilution and
the scatter contribution derived from acrylamide titration of a vesicle blank. The data
were analyzed according to the Stern-Volmer equation (Eftink and Ghiron, 1976) :
F0/F=1+Ksv[Q]
where F0 and F are the fluorescence intensities in the absence and the presence of the
quencher (Q), respectively and Ksv is the Stern-Volmer quenching constant, which is a
measure for the accessibility of Trp to acrylamide.
4.2.4.5 Quenching of Trp emission by brominated phosphatidylcholines
The indicated LUVs were added to a temporin L solution (final concentration of 5 µM
in 5 mM Hepes, 0.1 mM EDTA, pH 7.0) and the emission spectra were recorded after
3h, averaging five spectra. The differences in the quenching of Trp fluorescence by
(6,7), (9,10), and (11,12)-Br2-PC were used to calculate the probability for location of
the fluorophore in the membrane using two methods, viz. the parallax method
(Chattopadhyay and London, 1987) and distribution analysis (Ladokhin et al., 1993).
In the first one, the depth of the Trp residue is calculated as
Zcf = Lc1 + [(-ln (F1/F2)/πC)-L212]/2L21
where Zcf is the distance of the fluorophore from the center of the bilayer, Lc1 is the
distance of the shallow quencher from the center of the bilayer, L21 is the distance
between the shallow and deep quencher, F1 is the fluorescence intensity in the
presence of the shallow quencher, F2 is the fluorescence intensity in the presence of
the deep quencher, and C is the concentration of quencher in molecules/Å2. In
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distribution analysis, the depth of the Trp residue is calculated by fitting the data to
the following equation:
ln (F0/Fh)⋅c(h) = [S/σ (2π)1/2]⋅exp [-(h-hm)2/2σ2]
where F0 is the intensity in the absence of the brominated phospholipids, Fh is a set of
intensities measured as a function of vertical distance from the bilayer center to the
quencher (h), c(h) is the concentration of different quenchers, S is the area under the
curve (a measure of the effectiveness of quenching), σ is the dispersion (a measure
from the distribution of the depth in the bilayer), hm is the most probable position of
the fluorophore in the membrane bilayer, and h is the average bromine distances from
the bilayer center, based on X-ray diffraction and taken to be 10.8, 8.3, 6.3 for (6,7)-,
(9,10)-, and (11,12)-Br2-PC, respectively (McIntosh and Holloway, 1987). When
equal concentrations of the Br-lipids are used the value for c(h) is unity (Ladokhin,
1999).
4.2.5 Circular dichroism measurements
UV CD spectra from 250 nm to 190 nm were recorded with a CD spectrophotometer
(Olis RSF 1000F, On-line Instrument Systems Inc., Bogart, GA, USA) with
temperature maintained at 25 °C.  A one mm path length quartz cell was used at final
concentrations of 50 µM and 3 mM of the peptide and liposomes, respectively.
Interference by circular differential scattering by liposomes was eliminated by
substracting CD spectra for liposomes from those recorded in the presence of the
peptide. Data are shown as mean residue molar ellipticity (deg cm2dmol-1) and
represent the averages of five scans. The percentage of helical content was estimated
from the molar ellipticity at 222 nm (θ222), as described previously (Bernstein et al.,
2000).
4.2.6 Assay for phospholipase A2
Phospholipase A2 activity was determined by a kinetic assay described previously
(Mustonen and Kinnunen, 1991, 1992; Thuren et al., 1986, 1988). The indicated lipids
were mixed in chloroform and then dried under a stream of nitrogen followed by high
vacuum for a minimum of 2 h. The lipid residues were subsequently dissolved in
ethanol to yield a lipid concentration of 50 µM and small unilamellar liposomes
(SUVs) were formed by rapidly injecting this lipid ethanolic solution into the buffer
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(Batzri and Korn, 1973). The lipid concentration was 1.25 µM for both PPHPC and
PPHPM/POPG (5:5, molar ratio) liposomes in a total volume of 2 ml. After 15 min of
equilibration the reactions were initiated by adding 50 ng bee venom sPLA2 or 0.5 µl
of human lacrimal fluid. The progress of phospholipid hydrolysis was followed by
measuring the pyrene monomer intensity at 400 nm as a function of time at 37 0C.
Fluorescence intensities were measured with a Perkin-Elmer LS 50B spectrometer
with excitation wavelength of 344 nm and both emission and excitation bandpasses
set at 4 nm. The assay was calibrated by adding known picomolar aliquots of (pyren-
1-yl)hexanoate into the reaction mixture in the absence of enzyme while detecting
pyrene monomer emission intensity. The activity of the enzyme was calculated from
the initial velocity of the reaction kinetic curves and converted to the amount of
product released per unit time. The assays were carried out both with and without
added 5 mM Ca2+. Under the former conditions approx. 10 µM residual Ca2+ was
present, as determined by titration with EDTA.
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5 RESULTS
5.1 Penetration of Antimicrobial Peptides into Lipid Monolayers
The four antimicrobial peptides, magainin 2, indolicidin, temporin B and L readily
inserted into SOPC monolayers and the penetration of these peptides into the lipid
monolayer was progressively augmented when the content of the acidic phospholipid
POPG in the film was increased (publications I and II, Figs. 1). However, the impact
of PG on their penetration was significantly different, with a distinct ‘cross-over’
point at ≈ 38, 32, and 44 mN/m for indolicidin, temporin B and L, respectively. In
contrast, the slopes for ∆π vs π0 for the penetration of magainin 2 remained unaltered
by the presence of PG. The values for πc abrogating the intercalation of magainin 2
into the monolayer were thus increased from approx. 35 mN/m (XPOPG=0) to approx.
39 (XPOPG=0.1), 43 (XPOPG=0.2), and 46 mN/m (XPOPG=0.4). Furthermore, the
inclusion of cholesterol (X=0.10) into the SOPC film had no significant effect on the
penetration of magainin 2 while suppressed the insertion of indolicidin, temporin B
and L into the lipid monolayer. Interestingly, the kinetics of the increase in surface
pressure for temporin B were distinctly different from magainin 2, indolicidin and
temporin L (publication II, Fig.1, panels A and B). Accordingly, after the addition of
temporin B into the subphase there was a fast transient peak in π, followed first by a
relaxation and subsequently by a slow increase in π. These kinetics were independent
of lipid composition and initial surface pressure varied in the range of 12 to 36 mN/m.
In contrast, for magainin 2, indolicidin, and temporin L the value for surface pressure
increased in a continuous manner, reaching a plateau within approx. 40 min. The
kinetics were not investigated in more detail at this stage.
5.2 Effects of Antimicrobial Peptides on Lipid Dynamics in Bilayers
Consequences of the association of the peptides with liposomes were subsequently
studied by recording the emission spectra for the pyrene-labeled fluorescent
phospholipid and the anisotropy of DPH incorporated into LUVs. For SOPC LUVs
the addition of magainin 2 caused significant quenching of pyrene fluorescence (Fig.
3, panel A). Upon increasing XPOPG progressively enhanced Im (RFIm) was observed.
Magainin 2 caused only insignificant changes in Ie/Im at XPOPG=0 and 0.1, whereas at
XPOPG=0.2 and 0.4, decrements were evident (Fig. 3, panel B). In the presence of
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cholesterol (Xchol=0.1), both Im and Ie decreased dramatically by magainin 2, with
insignificant changes in Ie/Im (Fig. 3, panels A and B). Similarly to magainin 2,
indolicidin caused a parallel decrease in both Im and Ie for SOPC LUVs (Fig. 4, panel
A). However, quenching of pyrene fluorescence was evident also when the acidic
phospholipid POPG was present. The largest decrease in Im was observed at Xchol=0.1
(Fig. 4, panel A). In spite of the decrease in Im, Ie/Im revealed no significant changes
due to indolicidin (Fig. 4, panel B). Similarly to magainin 2 and indolicidin, temporin
B and L influence the quantum yields of pyrene-labeled phospholipids. Quenching of
pyrene monomer and excimer fluorescence by temporin B and L was evident in
zwitterionic membranes although the decrement in emission was less in the presence
of cholesterol (Xchol=0.1, Figs. 5 and 6, panels A and C). When the acidic
phospholipid was present at XPOPG=0.1 temporin B caused only insignificant changes
in Im, and upon increasing XPOPG from 0.2 to 0.4 Im increased in a progressive manner.
Also Ie was increased by temporin B in the presence of POPG (Fig. 5, panel C).
Interestingly, at XPOPG=0.4 the values for Ie increased progressively up to temporin
B/lipid molar ratio of ≈ 1/15, whereas upon exceeding this stoichiometry Ie decreased.
Temporin B caused Ie/Im to increase for SOPC LUVs while only minor changes in
Ie/Im were observed in the presence of cholesterol (Xchol=0.1, Fig. 5, panel B). The
increment in Ie/Im was progressively enhanced by increasing XPOPG from 0.1 to 0.2. At
XPOPG=0.4 Ie/Im increased at a temporin B/lipid molar ratio of ≈ 1/30. However, above
this peptide/lipid ratio, temporin B caused Ie/Im to decrease and insignificant changes
in Ie/Im were observed above a peptide/lipid ratio of 1/6. In contrast to temporin B,
temporin L decreased Im also for LUVs containing POPG, with the largest effect at
XPOPG=0.1 (Fig. 6, panel A). The decrement in Im was progressively attenuated with
increasing contents of POPG in the liposomes. Similarly to Im the decrement in Ie due
to temporin L was progressively attenuated with increasing XPOPG (Fig. 6, panel C).
At XPOPG=0.1 a clear discontinuity was evident, corresponding to POPG/temporin L
molar ratio of 1/1 and thus suggesting stoichiometric complex formation. Ie/Im for
SOPC LUVs slightly increased upon the addition of temporin L, whereas a significant
increase was observed in the presence of POPG (Fig. 6, panel B). While minor
difference of the increment in Ie/Im due to temporin L was evident at XPOPG=0.1, 0.2,
and 0.4 below a temporin L/lipid molar ratio of ≈ 1/10, the increments in Ie/Im at
XPOPG=0.2 and 0.4 were significantly higher than those at XPOPG=0.1 above a
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temporin L/lipid stoichiometry of ≈ 1/8. Likewise, Ie/Im increased further at XPOPG=0.4
above temporin L/lipid stoichiometry of 1/6 (Fig. 6, panel B).
The antimicrobial peptides, magainin 2, indolicidin, temporin B and L caused
virtually no changes in r in the absence of the acidic phospholipid (Figs. 3 and 4,
panels C, Figs. 5 and 6, panels D, respectively). However, progressively augmented
lipid packing and acyl chain order upon the addition of the four antimicrobial peptides
were evident with increasing XPOPG. Enhanced membrane order by the incorporation
of cholesterol in the membrane is revealed by the increase in r before the addition of
the peptides, as reported previously (van Ginkel et al., 1989). Magainin 2, temporin B
and L had no further effect on r in the presence of cholesterol (Xchol=0.1). In contrast,
the increment in the membrane acyl chain order due to indolicidin was observed in the
presence of cholesterol (Fig. 4, panel C). Accordingly, lack of changes in acyl chain
order or an increase in membrane order thus cannot cause the observed increase in
Ie/Im, revealing that peptide-induced segregation of lipids, viz. clustering of
fluorescent probe in the membrane occur.
60
Fig. 3. Effects of magainin 2 on lipid dynamics in LUVs assessed by fluorescence of pyrene-labeled
phospholipid analogs (X=0.01) and on the steady-state emission anisotropy r of DPH (X=0.002) (panel
C), shown as changes in pyrene monomer emission intensity Im (panel A) and excimer to monomer
ratio R(Ie/Im) (panel B). PPDPC was used in SOPC and SOPC/cholesterol LUVs, and PPDPG in LUVs
containing POPG. Liposomes were composed of SOPC with XPOPG=0  (), 0.1 (), 0.2 (), and 0.4
(), and with Xchol=0.1 (∇). The concentration of lipids was 25 µM in a total volume of 2 ml of 5 mM
Hepes, 0.1 mM EDTA, pH 7.0. The temperature was maintained at 25 °C with a circulating waterbath.
Each data point represents the mean of triplicate measurements, with the error bars indicating ±S.D.
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Fig. 4. Effects of indolicidin on lipid dynamics in LUVs assessed by fluorescence of pyrene-labeled
phospholipid analogs (X=0.01) and on the steady-state emission anisotropy r of DPH (X=0.002) (panel
C), shown as changes in pyrene monomer emission intensity Im (panel A) and excimer to monomer
ratio R(Ie/Im) (panel B). Liposomes were composed of SOPC with XPOPG=0  (), 0.1 (), 0.2 (), and
0.4 (), and with Xchol=0.1 (∇). Otherwise conditions were as described in the legend for Fig. 3.
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Fig. 5. Effects of temporin B on lipid dynamics in LUVs assessed by fluorescence of pyrene-labeled
phospholipid analog PPDPC (X=0.01) and on the steady-state emission anisotropy r of DPH (X=0.002)
(panel D), shown as changes in pyrene monomer and excimer emission intensity Im (panel A), Ie  (panel
C), respectively, and excimer to monomer ratio R(Ie/Im) (panel B). Liposomes were composed of SOPC
with XPOPG=0  (), 0.1 (), 0.2 (), and 0.4 (), and with Xchol=0.1 (∇). The concentration of lipids
was 20 µM. Otherwise conditions were as described in the legend for Fig. 3.
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Fig. 6. Effects of temporin L on lipid dynamics in LUVs assessed by fluorescence of pyrene-labeled
phospholipid analog PPDPC (X=0.01) and on the steady-state emission anisotropy r of DPH (X=0.002)
(panel D), shown as changes in pyrene monomer and excimer emission intensity Im (panel A), Ie  (panel
C), respectively, and excimer to monomer ratio R(Ie/Im) (panel B). Liposomes were composed of SOPC
with XPOPG=0  (), 0.1 (), 0.2 (), and 0.4 (), and with Xchol=0.1 (∇). The concentration of lipids
was 20 µM. Otherwise conditions were as described in the legend for Fig. 3.
5.3 Effects of Antimicrobial Peptides on Membrane Topology
The impact of the antimicrobial peptide magainin 2, indolicidin, temporin B and L on
the 3-D topology of macroscopic membranes were studied using giant liposomes with
different lipid compositions. SOPC membranes were unaffected by magainin 2,
indolicidin, and temporin B even when exposed to high amounts of the peptides (data
not shown). Likewise, giant liposomes composed of SOPC/cholesterol (Xchol=0.1)
were unaffected by magainin 2 and temporin B (data not shown). In contrast,
indolicidin had a significant effect on SOPC/cholesterol giant vesicles (publication I,
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Fig. 8) and temporin L induced pronounced vesiculation of zwitterionic membranes
although the vesiculation of giant liposomes containing cholesterol was attenuated
(publication II, Figs. 7 and 9). Similarly to the monolayer penetration and the effects
of the four antimicrobial peptides on the bilayer dynamics, the impact of the peptides
on the topology of giant liposomes was significantly enhanced by the presence of
POPG (XPOPG=0.1, publication I, Figs. 6 and 7, and publication II, Figs.6 and 8). All
the four antimicrobial peptides induced an endocytosis-like process in the acidic
phospholipid containing giant liposomes although the aggregated structures were
different. More specifically, the ‘endocytotic’ vesicles caused by magainin 2 and
temporin B remained separated from each other inside the giant liposomes and
aggregation of particles on the surface of the giant vesicles was  observed (publication
I and II, Figs. 6). In contrast, indolicidin and temporin L induced the formation of a
tightly packed 3-D structure on acidic phospholipid membranes with progressive
accumulation of a number of ‘endocytotic’ particles inside the giant liposomes upon
the subsequent addition of the peptides (publication I, Fig. 7, and publication II, Fig.
8). Compared to magainin 2, indolicidin, and temporin B, temporin L caused strongest
effects on the topology of giant liposomes. More specifically, in the presence of
POPG the area of the giant liposome surface exposed to temporin L became dark,
revealing a pronounced change in the refractive index and indicating the formation of
a tightly packed 3-D structure (publication II, Fig. 8). Subsequently, a group of
strongly aggregated vesicles emerged inside the cavity of the giant liposome. Further
addition of temporin L caused the area of the dark domain as well as the size of the
aggregated structure to increase. Interestingly, after the addition of approx. 60 fmol of
temporin L the aggregate formed inside the giant liposome became very large
(publication II, Fig. 8, panels E and F). Concomitant vesiculation of the neighboring
giant liposomes was also observed.
5.4 Interaction of Temporin L with Model Membranes
5.4.1 Secondary structure of temporin L
The structure of temporin L in zwitterionic (SOPC) and negatively charged
phospholipid (POPG) containing bilayers was investigated using circular dichroism
(publication III, Fig. 1). In an aqueous solution, temporin L adopts a random coil
conformation, revealed by the single minimum at 200 nm. However, in the presence
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of SUVs the peptide is α-helical, with the characteristic double minima at 210 and
222 nm. Compared to the zwitterionic SOPC SUVs, the helical conformation is more
pronounced in the presence of POPG, with the calculated helical content increasing
from 69% to 89% at XPOPG= 0 and 0.4, respectively.
5.4.2 Binding of temporin L to liposomes
Temporin L in buffer has fluorescence emission maximum at 352 nm (publication III,
Fig. 2, panel A), typical for Trp in a polar environment (Breukink et al., 1998). Upon
the addition of SOPC liposomes, a blue shift of the fluorescence emission maximum
of Trp4 was observed, while the emission intensity (F) was attenuated (publication III,
Fig. 2, panel A). In addition, the association of temporin L with SOPC vesicles caused
decrement in F up to the highest lipid/peptide molar ratio used (publication III, Fig. 2,
panel D). However, in the presence of POPG a pronounced increase in F and a blue
shift were evident, the increase being progressively enhanced with increasing XPOPG
in the membranes (publication III, Fig. 2, panel B). A sigmoidal dependence of the
blue shift was evident at all lipid compositions studied and the blue shift was more
pronounced in the presence of POPG (publication III, Fig. 2, panel C). Compared to
SOPC LUVs smaller lipid concentrations were required to obtain the maximum effect
on peptide fluorescence when POPG was present in the bilayer, thus indicating higher
affinity of temporin L for liposomes containing the acidic phospholipid. Interestingly,
in the presence of cholesterol F decreased at all lipid/peptide molar ratios measured
whereas the decrement in F was augmented compared to SOPC LUVs (publication
III, Fig. 2, panel D). Smallest blue shift was evident in the presence of cholesterol
(Xchol= 0.10), suggesting cholesterol to attenuate the lipid binding of temporin L. In
addition, under the latter conditions the location of residue Trp4 in the bilayers
appears to become more superfacial (see below).
5.4.3 Quenching of Trp by acrylamide
Fluorescence of Trp4 decreased in a concentration-dependent manner by the addition
of acrylamide to the peptide solution both in the absence and presence of liposomes,
without other effects on the spectra (data not shown). However, in the presence of
liposomes, less decrement in fluorescence intensity was evident, thus revealing that
Trp4 is less accessible to the quencher in the presence of LUVs (publication III, Fig.
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3). Compared to the measurements in the absence of liposomes the values for the
Stern-Volmer quenching constant (Ksv) were decreased in the presence of SOPC and
SOPC/POPG LUVs (publication III, table 1), suggesting that Trp4 was buried in the
bilayers, becoming inaccessible for quenching by acrylamide. Comparison of Ksv
values for POPG containing and pure SOPC liposomes indicates that the binding of
temporin L to liposomes is enhanced by POPG. Accordingly, the values for Ksv were
decreased in the presence of POPG with essentially no difference at XPOPG= 0.2 and
0.4. Interestingly, Ksv for cholesterol containing liposomes is only slightly less than in
the absence of liposomes, yet significantly higher than the values measured for the
other lipid compositions. These data thus suggest the affinity of temporin L for
liposomes to increase in the order SOPC/cholesterol (Xchol= 0.1) < SOPC <
SOPC/POPG (XPOPG= 0.1) < SOPC/POPG (XPOPG= 0.2) ≈ SOPC/POPG (XPOPG= 0.4).
5.4.4 Quenching of Trp by phosphatidylcholines brominated at different
positions along the acyl chains (Br2-PCs)
The intercalation depth of Trp4 into the hydrophobic core of the bilayer can be
assessed from the quenching efficiency of Br-labeled phospholipids. While this Trp
was quenched significantly in a SOPC membrane by all three brominated lipids,
(9,10)-Br2-PC was most efficient (publication III, Fig. 4). Similar quenching profiles
were evident for POPG containing membranes while the overall quenching efficiency
was enhanced by the presence of the acidic phospholipid. Quenching of Trp emission
as a function of lipid/peptide molar ratio revealed a sigmoidal dependence
(publication III, Fig. 5). Interestingly, at XPOPG= 0.1 quenching of Trp4 by (6, 7)-Br2-
PC is more efficient at low lipid/peptide molar ratios and decreased with increasing
the concentration of liposomes. At XPOPG= 0.4 the extent of quenching was lower than
at XPOPG=0.2 for all brominated lipids. According to the quenching of Trp by
brominated phosphatidylcholines located in the bilayer with different distance from
the center of the bilayer, the penetration depth of Trp4 in bilayers was estimated by the
parallax method (Chattopadhyay and London, 1987) and distribution analysis
(Ladokhin et al., 1993; Ladokhin, 1997, 1999). The results revealed the Trp residue to
be buried in both SOPC and SOPC/POPG membranes at a distance of ≈ 8.0 ± 0.5 Å
from the center of the bilayer (publication III, Fig. 6). In addition, the insertion took
place at all lipid/peptide molar ratios tested and there were only insignificant
67
differences in the penetration depth except at XPOPG= 0.1. At XPOPG= 0.1 the depth of
bilayer penetration of Trp4 was shallow at a lipid/peptide molar ratio of 10 while the
peptide was immersed deeper upon increasing the concentration of liposomes.
Interestingly, least effective quenching by brominated lipids was evident in the
presence of cholesterol suggesting that temporin L was associated to the membrane
surface, in keeping with the observed efficient quenching by acrylamide (publication
III, Figs. 3-5). These data readily revealed that the partitioning of the peptide into
LUVs was reduced by cholesterol and the insertion of this peptide into the membrane
was shallow, with a distance of 9.5 ± 0.5 Å from the center of the bilayer for Trp4
(publication III, Fig. 6).
5.5 Modulation of the Activity of Secretory Phospholipase A2 by Antimicrobial
Peptides
The antimicrobial peptides, magainin 2, indolicidin, and temporin B and L were found
to modulate the hydrolytic activity of secreted phospholipase A2 (sPLA2) from bee
venom and in human lacrimal fluid. More specifically, hydrolysis of
phosphatidylcholine (PC) liposomes by bee venom sPLA2 at 10 µM Ca2+ was
attenuated by these peptides while augmented product formation was observed in the
presence of  5 mM Ca2+ (publication IV, Fig. 1). The activity of sPLA2 towards
anionic liposomes was significantly enhanced by the antimicrobial peptides at low
[Ca2+ ] and was further enhanced in the presence of 5 mM Ca2+ (publication IV, Fig.
2). Similarly, with 5 mM Ca2+ the hydrolysis of anionic liposomes was enhanced
significantly by human lacrimal fluid sPLA2 while that of PC liposomes was
attenuated (publication IV, Fig. 4). Interestingly, inclusion of a cationic gemini
surfactant in the vesicles showed essentially similar pattern on sPLA2 activity
(publication IV, Fig. 5), suggesting that the modulation of the enzyme activity by the
antimicrobial peptides may involve charge properties of the substrate surface.
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6 DISCUSSION
6.1 Surface Activity of Antimicrobial Peptides
Monolayer experiments revealed magainin 2, indolicidin, temporin B and L to be
highly membrane active. Although these antimicrobial peptides intercalated into
zwitterionic phosphatidylcholine monolayers, they interact preferentially with acidic
phospholipids, in keeping with their net cationic charge (Matsuzaki et al., 1991,
1995a, 1998; Ladokhin et al., 1997). Yet, the impact of PG on their penetration was
significantly different, with a ‘cross-over’ point for indolicidin, temporin B and L. In
contrast, the slopes for ∆π vs π0 for the penetration of magainin 2 remained unaltered
by the presence of PG. The data suggest that unlike in bilayers magainin 2 would not
adopt the vertical orientation (i.e. the long axis of its α-helix perpendicular to the
layer plane) in lipid monolayers. The possible significance of  the ‘cross-over’ point
to the mechanism(s) of action of these peptides warrants further studies. Qualitatively,
it is of interest that the more surface active peptides, temporin L and indolicidin have
higher values of ‘cross-over’ pressures. Intriguingly, the ‘cross-over’ point remains
virtually unaltered irrespective of lipid composition (i.e. presence of PG), thus
suggesting that it could be solely determined by surface pressure, irrespective of
electrostatic interactions. A possible mechanism is that at ‘cross-over’ surface
pressure, the peptides change their orientation in the monolayer in a pressure
dependant manner, perhaps from a parallel to perpendicular orientation of its long
axis with respect to the layer plane (publication I, Fig. 9, panels B and C), thus
reducing the area/peptide and decreasing ∆π. Furthermore, it is also possible that
some PG molecules which are electrostatically bound to the peptides become oriented
differently from the phospholipids in the monolayer (publication I, Fig. 9, panel C). In
other words, the peptides with their associated PG would form a supramolecular
complex, the orientation of which would be pressure dependent. The kinetics of the
increase in π caused by temporin B was different from that for magainin 2, indolicidin
and temporin L (publication II, Fig. 1, panels A and B), also suggesting a
conformational and/or orientational change following the initial intercalation of the
former peptide into the lipid film.
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6.2 Impact of the Antimicrobial Peptides on Bilayer Lipid Dynamics
The effects of antimicrobial peptides magainin 2, indolicidin, temporin B and L on
lipid dynamics in bilayers are pronounced. Although there are distinct differences in
the effects of these peptides on bilayer lipid dynamics, also several similarities were
evident. Accordingly, increment in DPH anisotropy r revealed that all these peptides
increased acyl chain order in the presence of the acidic phospholipid POPG, the
magnitude of this effect increasing with XPOPG. Likewise, lipid segregation was
induced in the presence of the acidic phospholipid. All these effects imply the
importance of the acidic phospholipid as well as the cationic charge of the peptides
for the interaction of the latter with biomembranes. Interestingly, all the four
antimicrobial peptides influence the quantum yields of pyrene-labelled lipids except
for magainin 2 and temporin B where quenching of pyrene fluorescence was
abolished in the presence of POPG while for temporin L and indolicidin quenching
was observed regardless of lipid composition. Both π-π interactions between pyrene
and Trp as well as contacts of the basic residues of the peptides with the fluorophore
resulting in π-cation interaction (Dougherty, 1996) may be involved in the quenching.
In addition, the microenvironment of the fluorophore could change due to the
interaction of antimicrobial peptide with membranes.
Due to the strong interaction of peptides with the membranes, e.g. temporin B at
XPOPG=0.40 (Fig. 5, panel B), different effects may contribute to the reduction of the
excimer formation of pyrene lipid analogue, as follows. First, the membrane bound
peptides could represent a mechanical barrier for the lateral diffusion of the
fluorescent probe. In other words the membrane associated peptides could statically
reduce excimer formation by occupying neighbouring positions of the probe and thus
increase the path length for the diffusion of the pyrene-labeled lipid between
collisions. Second, the rotational freedom of the lipid acyl chains adjacent to the
peptides could be reduced due to a peptide-lipid interaction. Finally, lipids adjacent to
the peptides could be partly immobilized and their exchange frequency (and that of
the pyrene molecules in this area) thus be significantly lower than in the bulk lipid
matrix.
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6.3 Effects of the Antimicrobial Peptides on the Topology of Giant Liposomes
Interestingly, all peptides studied so far in our laboratory induce an endocytosis-like
process in giant vesicles yet the differences observed in the aggregated structures
suggest different modes of association of the four peptides with membranes.
Vesiculation of giant liposomes required repeated applications of peptides and thus
imply a concentration dependent mechanism of action. ‘Pore’ or ‘channel’ structure
could form by inserted peptides with its associated phospholipids. Upon disintegration
of nearby ‘pores’ or ‘channels’, a supramolecular complex of peptides and lipids may
form, thus causing transient disruption of the bilayer. Simultaneously, some of the
peptide molecules translocate into the inner leaflet of the membrane (Matsuzaki et al.,
1995a, 1996), allowing the membrane to reorganize and ‘heal’. Alternatively, the
antimicrobial peptides could lack specific knob-into-hole packing, which is a general
characteristic of helical bundle membrane proteins (Langosch and Heringa, 1998) and
causes promiscuous aggregation. The latter may induce local phase transitions such as
the separation of lipid-peptide micelles from the bilayers, or local changes of the
membrane curvature due to the intercalating peptides, which would cause transient
collapse of the bilayer structure. These processes could relate to the vesiculation of
giant vesicles induced by the four antimicrobial peptides observed in our study.
The microscopy images revealed the formation of the macroscopic aggregates to be
asymmetric, i.e. to occur inside the giant vesicles. Similarly to our studies on the
formation of ceramide by sphingomyelinase (Holopainen et al., 2000), this vectorial
nature of the action of the antimicrobial peptides suggests that their asymmetric
application onto the outer surface results in an augmented bending rigidity as well as
negative spontaneous curvature in the membrane. However, elucidation of the
mechanism(s) requires further studies and the nature of the aggregates visible by
microscopy is of interest. To this end, the possibility that the lamellar liquid
crystalline phase would not represent thermodynamic equilibrium has been proposed.
Accordingly, dimyristoylphosphoglycerol has been demonstrated to transform into the
so-called ‘sponge’ phase (Schneider et al., 1999). The factors controlling the
formation of this phase remain poorly understood, however, lipid headgroup
interactions appear to be important. An intriguing possibility is that in addition to their
other effects on bilayers these antimicrobial peptides could trigger a transition of the
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bacterial lipid, phosphatidylglycerol from a lamellar liquid crystalline state into the
‘sponge’ phase, the latter representing the thermodynamic equilibrium. On the level
of thermodynamics this would also provide the driving force for the macroscopic
aggregation of the peptide-lipid complexes observed in giant liposomes. However,
also in this case the mechanistic basis would warrant further studies.
6.4 Mode of Action of Temporin L on Model Membranes
The characteristics of quenching of the Trp residue of temporin L by acrylamide and
brominated phospholipid in the presence of SOPC liposomes demonstrate that this
peptide inserts in part into the hydrophobic lipid phase of the bilayer. However, Trp4
fluorescence intensity of temporin L decreased upon its transfer from the buffer into a
SOPC membrane and the fluorescence intensity was further decreased in the presence
of cholesterol (publication III, Fig. 2, panels A and D). Temporin L could aggregate
upon binding to zwitterionic membranes. Accordingly, in these aggregates the Trp
residues may be in close proximity so as to result in Trp self-quenching and
quenching by the positive charges of the peptide, as suggested for nisin (Breukink et
al., 1998). Similar interpretation may apply to the decrement of fluorescence in POPG
containing membranes at lipid/peptide molar ratio < 10 (publication III, panel D).
Yet, quenching could also be due to the charged headgroup of POPG interacting
directly with the π-orbitals of Trp (De Kroon et al., 1990). The third and perhaps the
most likely possibility is π-orbital-cation interaction (Dougherty et al., 1996), which is
suggested by the close proximity of Trp4 and Lys7 in α-helical temporin L
(publication III, Fig. 7).
Quenching by acrylamide reveals that Trp4 of temporin L is shielded in the presence
of liposomes. However, although at lipid/peptide molar ratio of 100 the data indicate
the peptide to be quantitatively membrane bound this residue was not completely
inaccessible to acrylamide. Experiments with brominated phospholipids further
demonstrate most efficient quenching by (9,10)-Br2-PC in both SOPC and
SOPC/POPG containing membranes (publication III, Fig. 4). Yet, significant
quenching was also due to (6,7)-Br2-PC in which the bromines reside at a distance of
10.8 Å from the bilayer center. Combining these results with those from acrylamide
quenching experiments, we may conclude that not all of the peptides are bound within
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the lipid bilayer in a transbilayer state, and an equilibrium of orientational states
(inserted and surface associated) may exist (Huang, 2000). Calculation of the
penetration depth indicates that Trp4 resides at a distance of 8.0 Å ± 0.5 Å from the
bilayer center in SOPC and SOPC/POPG membranes (publication III, Fig. 6). The
length of temporin L in α-helical conformation is approx. 19.5 Å, thus corresponding
to about half of the thickness of a SOPC bilayer. In this α-helical peptide the distance
of Trp4 from the N-terminus is  approx. 6 Å. Accordingly, the N-terminus of temporin
L is likely to reside deepest in the lipid bilayer (publication III, Fig. 7). In the
presence of cholesterol most efficient quenching was observed for (6,7)-Br2-PC.
Together with the acrylamide quenching data, this suggests that under these
conditions most of the temporin L bound to this membrane is surface-associated.
Notably, the effects of temporin L on membranes were significantly decreased in the
presence of cholesterol (publication II). Cholesterol increases membrane acyl chain
order and stabilizes the bilayer structure (Rietveld and Simons, 1998) which could
prevent the penetration of temporin L into the lipid bilayer and decrease the extent of
membrane perturbation by this peptide.
The interaction of antimicrobial peptides with bilayers alters the organization of
membranes and makes them permeable. Several models have been proposed to
describe the molecular events taking place during the peptide-induced leakage of the
target cell (for a review, see Shai and Oren, 2001). Our studies reveal that temporin L
inserts into the hydrophobic core of the membranes in a cooperative manner. Either
‘toroidal’ or ‘barrel stave’ model would thus be feasible (Shai and Oren, 2001). One
α-helical monomer of temporin L could span one half of a bilayer. Accordingly, pore
formation by this peptide is likely to require dimerization (Mangoni et al., 2000). The
‘toroidal’ model suggested for magainin 2 involves five peptide helices together with
several surrounding phospholipids, forming a membrane-spanning pore (Ludtke et al.,
1996). For this mechanism the concentration of bromines near the peptide would be
rather different than in the bulk of the bilayer, particularly in POPG containing
membranes. This can be rationalized by the Br2-PCs being partially excluded from the
predominantly negatively charged lipid domains where the peptide is preferentially
bound. Such variation in the local distribution of the lipid probes could affect the
analysis of the quenching data by the parallax method while distribution analysis
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would remain unaffected (Ladokhin, 1999). However, calculation of the distance d of
Trp4 from the bilayer center by the parallax method and distribution analysis gave
similar values for SOPC and POPG containing membranes, thus suggesting that
partial segregation of lipids caused by temporin L has only insignificant effects on the
quenching profiles by the brominated lipids. In combination with the data revealing
that temporin L readily inserts into and perturbs zwitterionic SOPC bilayers, the
‘barrel stave’ model  (Shai and Oren, 2001) could be the most likely mechanism for
its action, as suggested for other temporins (Mangoni et al., 2000).
6.5 Modulation of The Activity of Secretory Phospholipase A2 by Antimicrobial
Peptides
A variety of membrane perturbants have been shown to affect the adsorption and
action of PLA2 (e.g. Jain et al., 1991; Mustonen and Kinnunen, 1991; Cajal and Jain,
1997). In keeping with this our present results demonstrate a profound impact of the
four antimicrobial peptides on the activities of sPLA2s. Interestingly, it has been
shown that secreted PLA2 (sPLA2) has antibacterial activity and represents an
important host defense molecule (Qu and Lehrer, 1998; Buckland and Wilton, 2000;
Nevalainen et al., 2000). The global cationic nature of group II phospholipase A2 (pI
> 10.5) appears to facilitate penetration of the anionic bacterial cell wall, which is also
characteristic for the antimicrobial peptides (Buckland and Wilton, 2000). In addition,
the considerable preference of phospholipase A2 and antimicrobial peptides for
anionic phospholipid interface provide specificity toward anionic bacterial
membranes as opposed to zwitterionic eukaryotic cell membranes. A bacterial
membrane is thus susceptible to enhanced hydrolysis while the host cell membrane
would remain intact. The results highlight the potential of concerted action between
sPLA2 and antimicrobial peptides as part of the innate response to infections,
particularly when more antibiotic resistant bacterial strains are emerging.
In distinction from enzymes acting on monomeric soluble substrates, PLA2s have
access to their substrate only within the membrane phase and are sensitive to the
curvature and physicochemical characteristics of the phospholipid membrane
(Lehtonen and Kinnunen, 1995; Burack et al., 1997; Gadd and Biltonen, 2000).
However, in this study a possible variation in the bilayer curvature would be unlikely
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to influence the comparison of the measured effects due to progressively increasing
concentrations of the added antimicrobial peptides on the enzyme activity.
Importantly, the effects of the four antimicrobial peptides on the structure of anionic
membranes in particular are pronounced (publications I and II). Reorientation of
peptides and formation of ‘channel’- or ‘pore’-like structures could occur and the
bilayer structure become locally destabilized. These peptides are likely to induce
complex dynamic structures in the membranes with a variety of substrate
configurations. ‘Structural defects’ in membranes caused by antimicrobial peptides
could enhance the penetration of sPLA2 and the hydrolysis of vesicles would proceed
at a much higher rate with augmented catalytic turnover of the bound enzyme.
Alternatively, the antimicrobial peptides could modulate sPLA2s activity by substrate
replenishment through peptide-mediated vesicle-vesicle contacts, similarly to melittin
(Cajal and Jain, 1997). Different effects of these peptides on membrane properties
may thus influence sPLA2 activity to different degrees.
Due to the neutral charge and high curvature of PPHPC SUVs, the four antimicrobial
peptides studied can be expected to bind weakly to the zwitterionic membrane surface
without inserting deeply into the hydrophobic core of the bilayers. At low [Ca2+] the
coverage of the interface by the peptides would decrease the area available for the
binding of sPLA2, resulting in inhibition due to a smaller fraction of the enzyme being
bound to the interface. Repulsion between Ca2+ and membrane bound positively
charged antimicrobial peptides could also affect the binding of sPLA2 to the
membrane. However, in the presence of 5 mM Ca2+ the activity of bee venom sPLA2
towards PPHPC was enhanced by all four antimicrobial peptides while under the
same conditions the activity of lacrimal fluid sPLA2 was attenuated. Bee venom and
lacrimal fluid sPLA2s belong to group III and group II sPLA2s, respectively.
Compared to the group III sPLA2s the interface binding surface of group II sPLA2s
contains a significant larger number of basic amino acids and has a highly cationic
character (Ghomashchi et al., 1998; Nevalainen et al., 2000). Furthermore, Ca2+ is
essential for the activity of PLA2s (Berg et al., 2001). Accordingly, the effects of
cationic antimicrobial peptides on the binding of these two enzymes to the substrate
could differ, resulting in different effects on the catalytic activities of bee venom and
lacrimal fluid sPLA2.
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Interestingly, while magainin 2, indolicidin, and temporin B and L differ in structural
parameters they had qualitatively identical effects on sPLA2 activity. Intriguingly,
comparison of zwitterionic and anionic vesicles as substrates for sPLA2 has revealed
an essentially similar pattern for the effects of adriamycin (Mustonen and Kinnunen,
1991), phorbol esters (Mustonen and Kinnunen, 1992), and polyamines (Thuren, et
al., 1986) on the activity of PLA2. Modulation of sPLA2 activity via similar changes
induced in the substrate by these peptides is thus suggested, implying a lack of a
direct and specific effect on the enzyme. Importantly, also the cationic gemini
surfactant SR-1 added to the vesicles showed a similar pattern on sPLA2 activity
(publication IV, Fig. 5), indicating that modulation of sPLA2 reaction by the above
cationic perturbants could involve alterations in the electric properties of the substrate
surface. Subsequently, changes in the extent of the association of the enzyme to
substrate could be involved. Due to the inherent complexity of the physicochemical
characteristics of the dynamic phospholipid/water interface harbouring the site of the
catalytic action of PLA2 it is difficult to distinguish at this stage between the various
possibilities outlined above. Furthermore, there is no reason to assume the above
possibilities to be mutually exclusive. More thorough studies are thus warranted to
establish the molecular level mechanism(s) involved. Yet, taken the importance of the
development of novel means to fight emerging antibiotic resistant strains such efforts
are clearly needed.
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7 GENERAL DISCUSSION AND CONCLUSION
The antimicrobial peptides exert their effects on cells by interacting with membrane
lipids and the influence of the lipid composition on their specificity is significant. The
cationic nature of the antimicrobial peptides facilitate their binding and disrupting
negatively charged membranes. The considerable preference of the peptides for
anionic phospholipids provides specificity toward anionic bacterial membranes as
opposed to zwitterionic eukaryotic cell membranes. In addition, cholesterol, which is
not found in bacterial membranes, attenuates the interaction of antimicrobial peptides
with membranes. The bacterial membrane is thus more susceptible to the
antimicrobial peptides while the host cell membrane would remain intact. However,
for the hemolytic peptides temporin L and indolicidin, they significantly bind and
permeate also zwitterionic membranes though they have higher affinity to anionic
phospholipid, further suggesting the important role of membrane lipids in the
specificity of antimicrobial peptides.
Magainin 2, indolicidin, temporin B and L increase acyl chain order and cause
segregation of acidic phospholipids, complexing them into supramolecular clusters.
Likewise, in the presence of the negatively charged phospholipid the pronounced
vesiculation and formation of endocytotic aggregates of giant liposomes caused by
these antimicrobial peptides are dose-dependent. Furthermore, their antimicrobial
action requires the initially asymmetric exposure of the target membranes to these
peptides, and relates to the relaxation of the system back to thermodynamic
equilibrium. All these effects are in keeping with cooperative membrane association
being necessary for their antimicrobial action, involving transmembrane orientation of
the peptides. However, the action of these antimicrobial peptides is not limited to
permeabilization of the membranes and disruption of the membrane properties, they
were also found to modulate the hydrolytic activity of secreted phospholipase A2 by
affecting the physical properties of the membrane. The concerted action between the
sPLA2 and antimicrobial peptides could improve the innate response to infections and
thus further highlight the great potential of these peptides as therapeutics.
The presented mechanisms, some of which relate to each other, have been suggested
to explain the molecular basis of antimicrobial peptides acting on membranes. In fact,
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the same peptide might interact with phospholipid membranes in different ways
depending on the peptide-to-lipid ratio, the lipid composition of the membrane, and
other experimental conditions. With the help of biophysical and biochemical methods,
the conformation, topology and dynamics of membrane-associated peptides and lipids
can be investigated in considerable detail.
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